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ABSTRACT OF DISSERTATION 
 
 
 
ANTERIOR CRUCIATE LIGMAENT INJURY-INDUCED ALTERATIONS IN 
INFLAMMATION AND MUSCLE PHYSIOLOGY 
 
 
Long term weakness and atrophy of the quadriceps muscle are a direct result of 
anterior cruciate ligament (ACL) injuries and persist for up to 10 years post injury. 
Muscle atrophy ensues regardless of ligamentous reconstruction surgery, indicating that 
muscle atrophy following injury is a function of the ligament rupture and not 
reconstruction surgery. Elucidating the mechanisms underlying quadriceps atrophy 
following ACL rupture is crucial for developing interventions to restore proper 
quadriceps size and mitigate weakness thereby allowing for improved patient function. In 
addition to understanding the specific mechanisms that contribute to quadriceps atrophy 
following ACL rupture, the timing of atrophic events that cause the decreased function of 
the quadriceps muscle must be elucidated to determine the best intervention strategy. 
Most studies involving human subjects are conducted post ACL reconstruction with 
limited emphasis on the cellular changes in muscle that could be responsible for the 
observed atrophy and weakness. Animal models involving open-knee surgery for ACL 
transection have been employed to investigate cellular mechanisms in muscle, but these 
models are not mimicking the human ACL rupture, which is a closed-knee injury.  Thus, 
there is a need for fundamental research of the timing and underlying mechanisms of 
inflammation and quadriceps atrophy following ACL injury. 
The purpose of this dissertation is twofold:  Firstly, to examine the relationship 
between serum and synovial joint inflammatory markers and proteomics in ACL 
deficient subjects; and to use those acquired data to identify potential cellular processes 
that may influence skeletal muscle and track those processes longitudinally in 
conjunction with changes in muscle size following a closed ACL injury in a rat model. 
The goals of these studies were to determine if a closed ACL rupture in the absence of 
surgical repair would induce persistent quadriceps atrophy, determine the relationship 
between ACL rupture and intra-articular and systemic inflammation, and investigate 
time-dependent cellular changes in the vastus lateralis muscle. Results indicate there is an 
increase in inflammatory cytokines (IL-1b (interleukin 1-beta) and IL-6(interleukin six)) 
in both the synovial joint fluid and systemic circulation following injury in humans. In 
     
 
the in vivo animal model of ACL rupture quadriceps atrophy was observed one week post 
injury, but muscle size unexpectedly recovered as early as 2 weeks. Gene expression of 
MAFbx and Murf-1 (atrophy markers) was elevated as early as 48 hours after ligament 
rupture. No signs of muscle damage were observed at any time point. This dissertation 
provides the first longitudinal investigation into the changes in muscle physiology 
following a closed ACL-rupture, informed  by a proteomic analysis of human serum and 
synovial fluid after an acute clinical ACL tear. The results of these studies begin to 
characterize a relationship between joint inflammation and muscle atrophy in the acute 
time period following ACL injury.  
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CHAPTER 1. INTRODUCTION 
Background 
 Anterior cruciate ligament (ACL) tears are one of the most common orthopedic 
injuries affecting more than 200,000 people a year, of all ages and activity levels.1 The 
complete tearing of this static stabilizer in the knee causes a cascade of events that 
ultimately leads to long-term dysfunction of the knee joint and quadriceps muscle. The 
quadriceps muscle is a group of four muscles working synergistically to extend the knee 
and provide dynamic stabilization and shock absorption.2 Persistent quadriceps weakness 
and atrophy is a hallmark of ACL injury and arguably the most detrimental result. 
Atrophy and weakness of this muscle group persists long after the injury and even 
surgical intervention causing joint instability,1,3 altered gait4, muscle activation failure5, 
and may contribute to the development of osteoarthritis.6,7 
In the wake of an ACL rupture there is a sustained increase in intraarticular 
inflammatory cytokines and cartilage breakdown markers present in the joint.8-14 The 
increase in inflammation within the synovial environment is important because chronic 
inflammation could be a contributing factor to alterations in the systemic environment as 
well as joint degradation15 and potential muscle atrophy.16 The exact mechanism leading 
to quadriceps  atrophy following injury is still unknown, but a link between the 
quadriceps and neural alterations has been well established.17-19 There is also evidence to 
support a potential cellular cross-talk between the joint and the muscle20  indicating that 
alterations to the quadriceps following ACL injury is multifactorial. Research efforts 
focused on the effects of ACL rupture on the quadriceps muscle tend to be confounded 
by limitations in human research and studies whose patient populations are post-surgical.  
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ACL rupture causes a deleterious cascade of events that includes joint inflammation, 
changes to the systematic environment and alterations to the quadriceps muscle. Changes 
to the local, systemic and muscular environment likely all contribute to the atrophy and 
muscle weakness seen clinically and elucidating the mechanisms responsible for atrophy 
and quadriceps dysfunction will aid in the development of interventions and treatment. 
The goal of ACL reconstruction surgery is to reinstate joint stability but even this 
stabilizing surgery has the potential to present an additional inflammatory burden to the 
joint21 and create an environment of sustained inflammation. This dissertation will begin 
to dissect how ACL injury affects the synovial fluid environment, the circulating serum 
in human patients and the quadriceps muscle using a novel pre-clinical animal model.  
 Quadriceps Atrophy Regardless of Reconstruction  
The current standard of care in the US is to reconstruct an ACL after injury surgically 
in order to restore biomechanical stability. Human research centered around the changes 
in muscle morphology following ACL injury is mostly cross-sectional in design and 
confounded by the presence of joint surgery. Non-operative treatment of ACL injury is 
less common, but the question becomes whether patients that remain ACL deficient also 
undergo weakness and atrophy like those who have surgery.  Conservative treatment 
following ACL injury is centered around regaining quadriceps strength along with 
normal mobility. The quadriceps and hamstring muscle groups have to be working 
synergistically in order for the knee joint to regain normal biomechanical function post 
ACL injury and the strength in both groups should be comparable to that on the non-
injured leg.  
3 
 
As far back as the 1960s Edstrom22 showed muscle atrophy in myosin type I fiber 
atrophy following chronic ACL injury. His group followed eight cases of patients with 
torn ACLs and demonstrated that five out of the eight patients with a chronic ACL injury 
had significant statistical differences in fiber type cross sectional area between the “red” 
and “white” fibers. Edstrom made a case of selective atrophy of the quadriceps muscle 
due to disuse.22 Tegner et al. in 198423 measured the isokinetic quadriceps and hamstring 
strength of sixteen patients with “old” anterior cruciate ligament tears after undergoing a 
twelve-week long thigh musculature strengthening program. Researchers found that 
before the training period quadriceps strength was significantly decreased compared to 
the non-injured limb. Over the next two time points, quadriceps strength increased but 
never reached the level of the non-involved limb and remained significantly different.23 
These studies indicate that patients who suffer from ACL rupture will have decreased 
strength long term even after rehabilitation.  
Chapter two of this dissertation will discuss whether conservative treatment of ACL 
injury yields outcomes similar to reconstruction surgery. Patient reported function is not 
different between patients treated non-operatively and patients treated with reconstruction 
suggesting that surgery is not necessary to be functional in all cases.24 There is also 
evidence to suggest that the severity of the injury may have a role in the development of 
quadriceps weakness but overall those with a complete tear of the ACL had poor to fair 
muscular strength eight years after injury.25 In a comprehensive study done by Tsepis in 
200626, patients with an ACL injury were broken up into three groups depending on the 
length of time since injury. The short time group (less than six months) and then a 
medium (6 to 18 months) and a long-term group (average of 56 months). Quadriceps 
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strength was decreased by at least 20% percent for all groups compared to healthy control 
subjects.26 This shows a persistence of muscle weakness and decrease in cross sectional 
area5 well after injury and without reconstruction. While some studies  showed less 
weakness such as Patel et al., 200327 and Kvist et. al, 200128, all of the studies reported at 
least a 7% deficit in involved quadriceps strength. Chapter two of this dissertation is a 
critically appraised topic that will discuss the effect of non-operative ACL treatment on 
isokinetic muscle strength, function and patient reported function. Atrophy and weakness 
of the quadriceps muscle persists regardless of reconstruction, and patients who remain 
ACL deficient (ACLD) will continue to have quadriceps atrophy and joint dysfunction 
years following ACL injury. Research focused on the specific alterations in quadriceps 
function before reconstruction is lacking and there is a need for longitudinal studies to 
begin to fill the gaps in knowledge.  
Cellular Changes in Quadriceps muscle Following ACL Injury  
To start to identify the potential mechanisms of quadriceps atrophy after ACL 
rupture, researchers have turned to cellular measures of muscle morphology. Recent 
literature reveals differences in physiological cross sectional area (CSA) between injured 
and non-injured limbs with the largest decrease in muscle size in the vastus lateralis.29 
Furthermore, there was a specific decrease in the CSA of type-IIA muscle fibers 
preceding surgery. After reconstruction surgery, the frequency of type IIA muscle fibers 
significantly decreased in conjunction with increases in type IIA/IIX hybrid fiber types.30 
Muscle biopsies from the vastus lateralis of patients with an ACL injury reveal 
differences in physiological cross sectional area and pennation angle30, both of which are 
important for proper function of the quadriceps group. Following ACL injury there are 
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also significant increases in fibroblast and collagen content which correlated with 
increases in extracellular matrix.30,31 This is important because increases in extracellular 
matrix could potentially limit hypertrophy32 and therefore adversely affect function and 
recovery from injury. Moreover, the injured limb showed decreases in satellite cell 
number30,31, which could lead to a decreased capacity for muscle growth. Additionally, 
muscle biopsies from the injured limb had significantly higher myostatin gene expression 
and protein abundance.33  Myostatin is a potent negative regulator of muscle size34 and 
increases in myostatin may be an important factor in quadriceps atrophy following ACL 
injury. In addition, myostatin and TGF-b levels in serum were also increased following 
ACL reconstruction.35 Along with TGF-b, muscle from the injured limb also has 
increased protein abundance of the inflammatory cytokines IL-6 and TNFa. 33 Elevations 
in proinflammatory cytokines in serum mirror what is occurring in the joint post injury, 
for example elevations in both synovial fluid pro-inflammatory cytokines like IL-6 are 
similar to increases in cytokine receptor pathways in human serum. Increases in 
inflammatory cytokines may lead to a state of sustained inflammation providing a 
connection between the two environments. Changes in cross sectional area, extracellular 
matrix, muscle growth regulators and satellite cells provide compelling evidence that 
ACL injury causes a myriad of detrimental changes to the quadriceps muscle. There are 
also increases in apoptosis and denervated muscle fibers31 which could potentially 
explain some of the neurogenic response seen in patients after this injury. There is an 
abundance of literature to support alterations in neural feedback in the quadriceps after 
injury.17-19 Increases in denervated muscle fibers could begin to explain the quadriceps 
inhibition and lack of motor recruitment that is associated with weakness after ACL 
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rupture. This evidence demonstrates changes within the muscle itself following injury 
that likely work in combination to create changes within the neural feedback network that 
contributes to weakness.   
The literature presented above provides insight into understanding the complicated 
response of the quadriceps muscle to ACL rupture. It should be noted that the average 
time of the muscle biopsies in the above studies was 60 days post injury and therefore 
early events underlying muscle changes remain largely unknown.  There is also a 
limitation in the number of muscle biopsies that can be collected from human subjects 
with the majority of studies presented here just looking at biopsies from pre- to post-
reconstruction. Surgery presents a new insult to the joint and it is still unclear if that 
insult will further modify the quadriceps. Only having one time point pre-surgery 
prohibits a complete picture of longitudinal changes occurring after injury from being put 
together.  To augment the knowledge base while there is a lack of longitudinal human 
studies, animal models of ACL injury allow for a more in depth analysis of the 
quadriceps.  
Animal Models of ACL Injury   
The use of animal models allows researchers to study multiple time points post injury. 
Additionally, with animal models comparison between injured and non-injured limbs can 
be easily obtained. Also, animal studies provide more feasibility in the timing of sample 
collection allowing for longitudinal studies targeted at determining quadriceps changes 
during the acute post-injury period. Studies utilizing ACL transection models examined 
changes in quadriceps physiology at one, two, three, seven and fifteen days post 
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transection.36,37 Both studies show significant increases in two markers of muscle 
catabolism Murf-1 and Mafbx from days 1-3 over the control and sham groups.36,37 
Increases in these markers are important because Murf-1 and Mafbx are two ubiquitin 
ligases that are associated with protein breakdown and atrophy within skeletal muscle and 
have been shown to be upregulated in most atrophy models. 38,39 Additionally, muscle 
mass loss is preceded by the upregulation of Murf-1 and Mafbx.38,39 Similar to the human 
studies outlined above33,35, significant increases in myostatin over the early post 
transection period that persisted out to seven days post-surgery coincide with decreases in 
muscle wet weight and cross sectional area.36,37,40 Furthermore, decreases in muscle fiber 
CSA and significant increases in Murf-1 and Mafbx mRNA are found 60 days post ACL 
transection, indicating that increases in muscle atrophic signaling are present after the 
acute recovery period.41  
 While increases in synovial inflammation indicate that an animal model of ACL 
transection will undergo a similar inflammatory response to that of humans within the 
knee joint.41 One important consideration when looking at animal models of ACL 
transection as an injury is that surgically transecting the ACL may not be as clinically 
relevant since surgical transection creates inflammatory and atrophic processes that 
mimic ACL reconstruction surgery.36,42  The additional surgery in order to achieve 
transection of the ACL in traditional animal models has the potential to create an inflated 
inflammatory response which makes it more difficult to discern which alterations in 
quadriceps muscle are due to the ruptured ligament as opposed to a state of increased 
inflammation after a surgery. This distinction may be important as  there is evidence to 
support that any intraarticular inflammation may play a role in muscle atrophy by 
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inducing Murf-1 by upregulations in NF-kb and TNF signaling pathways.16,43 
Furthermore, it has been shown that pro-inflammatory cytokines like IL-6 have the 
ability to induce muscle atrophy by decreasing phosphorylation of ribosomal S6 kinase.44 
It is highly likely that inflammation plays a large role in the induction of atrophy post 
ACL rupture and therefore ACL transection models requiring open surgery may not be 
best to study this injury since an increase in inflammation will confound the effects to the 
quadriceps muscle. 
Goal of Dissertation  
There is a fundamental lack of knowledge about the mechanisms underlying 
quadriceps atrophy following ACL injury. There is evidence for cellular changes to the 
quadriceps muscle, but in humans the data are primarily cross sectional and lacks 
consistent study time points. Moreover, human studies have mainly focused on 
quadriceps atrophy following reconstruction and not just injury. However, atrophy is 
present regardless of ACL reconstruction indicating that the initial ligament rupture is a 
contributing factor. There is a need for a clinically relevant non-transection model of 
ACL injury to longitudinally track alterations in the quadriceps muscle. 
In this dissertation we proposed to examine the connection between synovial joint 
inflammation and quadriceps atrophy following ACL injury in both human and animal 
models. Quadriceps deficits following injury are present with or without reconstruction, 
indicating that quadriceps atrophy is present even in ACL deficient patients. Next, in 
chapter three, we examine the inflammatory response in human synovial fluid following 
ACL injury and see that injury causes a sustained increase in proinflammatory cytokines 
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IL-1b and IL-6. Based on the inflammatory response in the synovial joint, human serum 
was profiled to determine if increases in circulating markers of inflammation was similar  
to synovial fluid and if these proteins have the potential to influence the catabolic balance 
of skeletal muscle. As such, chapter four chapter focuses on human serum proteomics 
following ACL injury. The results of that study indicate systemic increases in not only 
inflammation but also  muscle specific markers like myoglobin, which traditionally used 
as a “stress” marker for muscle and while this specific marker was not pursued farther, it 
raised questions about potential muscle damage following ACL injury. Our hypothesis is 
that the vastus lateralis is subjected to damage during ACL tear leading to atrophy and 
dysfunction. To test this hypothesis, a novel in vivo animal model of ACL tear was used. 
The model consists of a device that will mechanically overload the tibia in relation to the 
femur, tearing the ACL. By tearing the ACL in a closed system where there is no increase 
in inflammation from a surgery, makes this  clinically relevant model of injury. Our team 
now has the ability to study the quadriceps muscle acutely after injury allowing us to 
answer questions about the quadricep muscles response to ACL rupture alone at various 
time points after injury. Chapter five describe results from the animal model focusing on 
damage and atrophy markers acutely after ACL rupture. 
 
 
CHAPTER 2. THE EFFECTIVENESS OF NON-OPERATIVE TREATMENT FOR ANTERIOR 
CRUCIATE LIGAMENT RUPTURE ON PATIENT REPORTED OUTCOMES AND MUSCULAR 
STRENGTH: A CRITICALLY APPRAISED TOPIC  
Abstract  
Clinical Scenario:  Anterior Cruciate Ligament (ACL) ruptures are one of the most 
common injuries in young athletic populations. The leading treatment for these injuries is 
anterior cruciate ligament reconstruction (ACL-r), however, non-operative treatments are 
also utilized. Following ACL-r, patients experience prolonged muscle weakness and 
atrophy of the quadriceps muscle group, regardless of rehabilitation. Non-operative 
treatment plans following ACL injury exist, but their outcomes are less familiar, in spite 
of providing insight as a non-surgical ‘control’ for post-surgical rehabilitation outcomes. 
Therefore, the purpose of this critically appraised topic (CAT) was to evaluate quadriceps 
strength and function following non-operative ACL rehabilitation using objective and 
subjective measures including: Isokinetic dynamometry; the Single Leg Hop Test; and 
the International Knee Documentation Committee Subjective Knee Form (IKDC).  
Focused Clinical Question: In patients who have sustained an anterior cruciate ligament 
rupture, what are the effects of non-operative treatment on peak isokinetic knee extensor 
torque, the Single Leg Hop Tests and the IKDC? Key Findings: Patients who underwent 
non-surgical ACL treatment produced limb symmetry index (LSI), the side-to-side torque 
difference expressed as a percentage, values at or above 90% for all four Single Leg Hop 
Tests and strength tests similarly to ACL-r patients. All studies showed individuals had 
higher IKDC scores at baseline collection when compared to patients who underwent 
ACL-r but showed lower IKDC scores at long term follow up compared to ACL-r 
patients.  Clinical Bottom Line: Non-operative treatments of ACL injuries yield similar 
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long-term results in quadriceps strength as ACL-r.  Due to the quality of evidence and the 
absence of randomized controlled trials on this topic, these outcomes should be 
considered with caution. Strength of Recommendation:  The Oxford Centre for Evidence-
Based Medicine taxonomy recommends a grade of B for level 2 evidence with consistent 
findings. 
Keywords: ACL, treatment, muscle strength, function  
Full Reference: Hunt, E. R., Parise, C. N., & Butterfield, T. A. (2020). The Effectiveness 
of Nonoperative Treatment for Anterior Cruciate Ligament Rupture on Patient-Reported 
Outcomes and Muscular Strength: A Critically Appraised Topic. Journal of Sport 
Rehabilitation, 1(aop), 1-6. 
Clinical Scenario  
Anterior cruciate ligament (ACL) injuries, are among the most common traumatic 
athletic injuries, affecting upwards of 200,000 individuals per year in the United States 
(US).1 For those US patients who wish to continue participation in competitive athletics, 
ligament reconstruction has become the preferred method of treatment.45 In the US, the 
rate of ACL reconstruction continues to rise annually, reaching 52 reconstructions per 
100,000 of the population in 2015.46 This rate is second to Australia, who continues to 
lead the world with 77.4 ACL reconstructions per 100,000 citizens, with the greatest 
increase in ACL reconstructions among those 4-15 years of age.47    
The primary purpose for ACL reconstruction (ACL-r) is the restoration of joint 
congruity concomitant with increased knee stability.48 However, despite the 
advancements and improvements in surgical techniques, instrumentation, and post-
surgical care and rehabilitation, individuals who undergo ACL–r inevitably suffer from 
persistent quadriceps atrophy and weakness long term.49 These unresolved strength 
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deficits decrease athletic performance,  increase the risk of re-injury,50 and likely 
contribute to the progression of cartilage damage within the joint.51 Therefore, the dogma 
that ACL-r is the most efficacious treatment following ACL injury should be taken with 
caution. In a twenty-one-year population study, Sanders et al., found that out of almost 
two thousand patients, 75% of them underwent ACL-r and 98% of those were under the 
age of 18.24 Although the rates of non-operative treatment of ACL injury continue to lag 
behind the rate of surgical intervention in the US, there is growing support within the 
international community for conservative treatment. Therefore, the purpose of this 
critically appraised topic is to review the best, and most current literature that measured 
the effects of conservative, non-operative ACL treatment on quadriceps strength and 
patient perceived function using Isokinetic dynamometry; the Single Leg Hop Test; or the 
International Knee Documentation Committee Subjective Knee Form (IKDC).   
 Focused Clinical Question  
In patients who have sustained an anterior cruciate ligament rupture, what are the 
effects of non-operative treatment on isokinetic muscle strength, the Single Leg Hop 
Tests and the IKDC-2000?  
Search Strategy  
In November of 2018, we performed a comprehensive computerized search using the 
following terms (Figure 2.1), using the PICO strategy. 52 
• Patient/Client group: anterior cruciate ligament rupture  
• Intervention: non-operative treatment protocol  
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• Comparison: ligamentous reconstruction OR no  
• Outcome: patient reported outcomes AND muscular strength 
2.1.1 Sources of Evidence Search  
• EBSCOhost 
o CINAHL  
o SPORTDiscus  
o Medline  
o Additional resources obtained via review of 
reference list and hand search  
Inclusion and Exclusion Criteria  
The criteria for inclusion were as follows:  
• Studies that investigated the effectiveness of non-operative treatments  
• Studies that investigated ACL ruptures  
• Studies that included outcome measures of patient reported outcomes or muscular 
strength  
• Limited to studies published within the past 10 years (2008-2018) 
• Limited to English  
• Level 2 evidence or higher  
The criteria for exclusion were as follows: 
• Studies that investigated non-ACL ruptures (i.e. ACL partial thickness tear) 
 
• Studies that investigated other subsequent pathologies because of ACL injury 
14 
 
• Studies that did not investigate the effects of non-operative treatment on ACL 
injury 
• Studies that were not in English  
• Level 3 evidence or lower  
• Systematic reviews and meta-analysis 
2.1.2 Evidence of Quality Assessment  
The Strengthening of Reporting of Observational studies in 
Epidemiology (STROBE) Statement was used to determine the 
validity of the included studies. Two authors (EH, CP) 
independently scored and reviewed each of the articles, after 
review both authors (EH, CP) reached an agreement about study 
quality and inclusion.  
Summary of Search and Key Findings  
• The literature search returned 43 studies (Figure 2.1) related to the clinical question. 
After review 39 studies were excluded because they did not meet the inclusion 
criteria for this CAT. Four prospective cohort studies48,53-55 met inclusion criteria and 
are described in Table 1. 
• Each included study evaluated the effects of non-operative treatment algorithms for 
ACL injury or compared conservative treatment and ACL-r.  
• Collectively, the four studies (Table 2.1) reported significant improvements in both 
patient reported outcomes and muscular strength when comparing long term follow 
up to the time of injury. In addition, in the studies that compared the effects of non-
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operative treatment with ACL-r, outcome measures were similar between the two 
groups.  
Results of Evidence Quality Assessment  
Four studies were identified as the best evidence and selected for inclusion in this 
critically appraised topic (CAT). The four studies were selected because they were level 2 
evidence and had STROBE scores of at least 17/22. Three studies 48,54,55 examined the 
effects of non-operative treatment on isokinetic strength of the quadriceps and 
hamstrings. In addition, studies conducted by Moksnes et al., 48,53,54 examined the effects 
of non-operative treatment on strength using the Single Leg Hop Test and Moksnes et al. 
2009, was the only study to compare the non-operative ACL group directly to the ACL-r 
group. All four studies examined the effects of non-operative ACL treatment on the 
IKDC 2000. 48,53-55 Moksnes et al., 2008 received a validity score of 18/22 for failure to 
include the study design in the abstract, address potential sources of bias and discuss the 
external validity of the study. Moksnes et al., 2013 did not discuss potential confounders 
of each variable or the external validity of the study.  
Clinical Bottom Line  
There is strong evidence to support that conservative treatment of ACL injuries 
obtains similar outcomes as ACL ligamentous reconstruction at long-term follow up 
periods. All studies included in this critically appraised topic,48,53-55 generated similar 
results: at follow up patients who underwent non-surgical treatment of ACL injury 
produced LSI values at or above 90% for all four Single Leg Hop Test, as well as, knee 
extensor and flexor isokinetic muscular strength. In addition, all studies showed 
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individuals had higher IKDC-2000 scores (higher scores indicate better knee function) at 
baseline collection when compared to patients who underwent ACL-r but showed lower 
IKDC-2000 scores at long term follow up compared to ACL-r patients. There is grade B 
evidence that non-operative treatment yields satisfactory results in the long term. The 
Oxford Centre for Evidence-Based Medicine taxonomy recommends a grade of B for 
level 2 evidence with consistent findings.56 
Implications for Practice, Education and Future Research  
The prevalence of ACL injuries in athletes is increasingly escalating. While ACL-
r is the current favored treatment, it is important that all treatment options are carefully 
examined in order to provide patients with the most efficient and effective care. 
Therefore, this critically appraised topic was completed to evaluate the best literature 
regarding the use of non-operative treatment regimens for ACL injuries. Four cohort 
studies were included in the investigation. From these four studies, the main findings 
were concluded that non-surgical treatment of ACL injuries could yield satisfactory 
results when outcome measures include the IKDC-2000 at baseline, Single Leg Hop Test, 
and isokinetic muscle strength.   
 The IKDC is a knee specific, patient reported assessment tool used to evaluate 
symptoms, function during daily activities and levels of symptom free sports-activity.57 It 
has been determined to be a reliable and valid instrument for the outcome measures 
mentioned above and was therefore seen as an appropriate tool to be used in this critically 
appraised topic.58,59 However, it should be noted that in a study conducted by Kessler et 
al.,60 the IKDC scores were determined based upon tibio-femoral anterior-posterior 
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translation. Because patients who undergo ligamentous reconstruction have inevitable 
restoration of ligamentous stability, the comparison of anterior-posterior translation 
between groups of non-operative and ACL-r groups is not informative. Due to the use of 
this criteria as a scoring variable, future studies should take caution when using the IKDC 
as a tool of comparison between conservatively treated and ACL-r groups. It is important 
to note that while patient reported outcomes are reliable and valid tools, they are 
subjective to normal patient function and how the patient feels during a given time-frame. 
Several studies48,55 showed that patients who opted to go through non-operative treatment 
presented with better IKDC-2000 scores at baseline. However, the patient population of 
these non-operative groups was significantly older than the patients who decided to go 
through with ACL-r and had an altogether lower activity level.  This suggests that 
activities of daily living and pre-injury activity level are important factors when it comes 
to deciding between ACL-r and conservative treatment options.  
Unfortunately, persistent quadriceps weakness has become a comorbidity to ACL-
r and has spurred many novel treatments, rehabilitation programs and medical 
technologies in attempts to address this issue. However, strength deficits of 20% lasting 
for over two years have still been documented following ACL-r61-63. In three of the four 
studies included in this critically appraised topic, isovelocity torque output was used as a 
measure of quadriceps and hamstring strength in subjects treated conservatively 
following ACL injury53-55 All three studies used the following standard procedure: 10-
minute warm-up on a stationary bike followed by four practice trials performed with 
submaximal effort at 60°/sec. Finally, five test repetitions were performed with maximal 
effort at the same angular velocity of 60°/sec, starting with the uninvolved limb. Strength 
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deficits between extremities were reported as a limb symmetry index (LSI), or simply the 
side-to-side torque difference expressed as a percentage (peak torque of involved limb)/ 
(peak torque of uninvolved limb) x 100.  Although LSI values <90% are considered 
abnormal,64 Moksnes et al. 2007, and Moksnes et al. 2013 all reported quadriceps and 
hamstring LSI values at or above 90% at baseline and follow up. Moreover, Grindem et 
al. 2014 further reported that only nine out of 43 non-surgically treated patients exhibited 
quadriceps and hamstring LSI values of <90% at follow up. These findings demonstrate 
that non-operative treatments of ACL injuries have the possibility to produce desirable 
muscle strength. 
The Single Leg Hop Tests have been shown to be reliable and valid tests used to 
measure neuromuscular control and strength in the limb.65-67 The test only requires a 
standard tape measure making it accessible to clinicians in a variety of settings, and 
deficits between extremities can easily be reported as LSI values. Moksnes et al. 2013 
reported LSI values at or above 90% for all Single Leg Hop Tests at baseline and at all 
follow up periods (1 year and 2 years). Additionally, Moksnes et al. 2009 and Grindem et 
al. 2014 reported LSI values above 90% for all Single Leg Hop Tests at follow up, 
demonstrating that non-surgical treatments of ACL ruptures can improve neuromuscular 
control, strength and confidence as measured by the Single Leg Hop Test.  
Interestingly, all of the studies included in this CAT report baseline LSI values at 
or above 90%. This could be due to baseline outcomes being measured at least 6 months 
after injury. Outcome measures examined by Moksnes et al. 2008 did not get evaluated 
until at least two years after ACL injury. Additionally, it was routine for patients that 
were included in these studies to undergo pre-operative rehabilitation sessions to resolve 
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initial impairments of ACL injury. Recently, it was shown that patients who underwent 
ACL-r were typically returned to contact sports within six-months post-surgery.64,68 
Gridnem et al., reported that athletes who were treated non-operatively returned primarily 
to non-pivoting sports. Whether functional and strength differences exist between 
conservative and surgical treatment at the time when most highly active individuals are 
returned to sport is unknown and should be the focus of future studies.  
 The findings of this CAT imply that non-operative treatments of ACL injuries are 
adequate options in restoration of patient function, as well as patient strength at long term 
follow ups. However, patient goals, normal activities of daily living and sport activity 
level should all be taken into consideration when choosing the best treatment plan for 
patients. Furthermore, the absence of randomized control trials on this topic hinder the 
strength of these recommendations. While further investigation regarding this topic is 
warranted, patients should be thoroughly informed of all treatment options available. 
Evidence suggests that conservative treatment has the ability to generate positive 
outcomes in the long term and should be considered for ACL-deficient individuals.   
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Table 2.1  Characteristics of Included Studies 
 Study 1 
Moksnes et al. 
2008 
Study 2 
Moksnes et al. 
2009 
Study 3 
Moksnes et al. 
2013 
 
Study 4 
Grindem et al. 
2014 
Study/Design Prospective 
cohort study  
 
Prospective 
cohort study  
 
Prospective 
cohort study  
 
Prospective 
cohort study  
 
Participants 
 
26 patients, 11 
girls and 15 
boys were 
included 
throughout the 
entirety of the 
study. 20 
patients were 
treated non-
operatively 
while 6 patients 
were treated 
with ACL-r.  
 
At baseline, 125 
patients, 56 
females and 69 
males (age 27.2 
± 8.6). At 
follow up 102 
patients 
remained. 52 
patients in the 
non-operative 
group and 50 
patients in the 
ACL-
reconstruction 
(ACL-r) group.  
 
46 patients, 16 
females and 30 
males (age at 
baseline 11.8 ± 
1.3).  34 
patients 
remained in the 
non-operative 
treatment 
group and 10 
patients opted 
to undergo 
ACL-r.  
 
143 patients, 
80 females and 
63 males were 
included in the 
study. 43 
patients chose 
to be treated 
non-
operatively 
and 100 
patients were 
treated with 
ACL-r.  
 
Inclusion 
 
ACL injury 
before the age 
of 13, two years 
from injury to 
or 
reconstruction 
to follow up 
period, ACL 
rupture 
confirmed by 
magnetic 
resonance 
imagining, 
Level 1 or level 
2 activities, 
unilateral ACL 
rupture. 
 
Traumatic 
complete 
intrasubstance 
ACL injury 
sustained at the 
age of 12 or 
younger 
 
ACL injury 
within past 3 
months, MRI 
diagnosis, 
3mm 
difference 
between knees 
using KT-
1000, 13-60 
years old, 
participate in 
level 1 or level 
2 activities at 
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clinical 
examination by 
one experienced 
orthopedic 
surgeon and 
positive 
Lachman’s test.  
 
least 2x a 
week.  
 
Exclusion 
 
ACL avulsion 
injury, posterior 
cruciate 
ligament injury 
or intraarticular 
fractures.  
 
Posterior 
cruciate 
ligament injury, 
intraarticular 
fractures, 
symptomatic 
meniscal injury, 
cartilage injury 
affecting the 
subchondral 
bone plate, or 
any other injury 
to the leg.  
 
Tibial or 
femoral ACL 
avulsion 
fractures 
 
Current or 
pervious 
injury to 
contralateral 
leg if MRI 
showed 
another grade 
3 ligament 
injury, fracture 
or full-
thickness 
articular 
cartilage 
damage or 
patients with 
symptomatic 
meniscal 
injury  
 
Follow up 
Periods 
 
Follow Up: 
taken at a 
minimum of 2-
years post ACL 
injury.  
 
Baseline: 
Taken after 3 
months of 
rehabilitation 
program. 
Baseline testing 
within first 6-
months post 
index injury                                                          
1 Year Follow 
Up: One year 
after baseline 
measurement 
Baseline: 
Taken after 
patient 
completed 
phase two of 
the 
rehabilitation 
program 
previously
published by 
the 
investigators 
and could 
perform single 
Baseline: 
Taken at a 
mean of 2-
months post 
injury. Before 
baseline, 
completed 
rehabilitation 
to resolve any 
initial 
impairments 
from the 
injury.    
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OR one year 
after ACL-r.  
 
legged hops 
without pain. 
Mean time 
from injury to 
baseline testing 
was 11.7 ± 11.5 
months.                                                                                       
1 Year Follow 
Up:  One year 
post baseline              
2 Year 
Following up: 
Two-years post 
baseline 
 
Six-week test: 
taken after 
participation 
in the 5-week 
rehabilitation 
protocol 
described by 
Eitzen et al.                                                                                
2- year follow 
up: taken 2 
years after 6-
week test or 2 
years after 
ACL-r.  
 
Outcome 
Measure(s) 
 
Single legged 
hop tests (single 
hop, triple hop, 
triple crossover 
hop, 6-m timed 
hop), IKDC 
2000, isokinetic 
muscle strength 
of knee 
 
Single legged 
hop tests (single 
hop, triple hop, 
triple crossover 
hop, 6-m timed 
hop), IKDC 
2000                            
 
IKDC 2000 
(with the help 
of a parent), 
isokinetic 
muscle strength 
of the knee, the 
four Single 
legged hop 
tests.  
 
Isokinetic 
muscle 
strength of the 
knee, IKDC-
2000 
 
Main 
Findings 
 
IKDC mean 
score of 85 (71-
95). All Single 
legged hop tests 
above 90% LSI. 
Both quadriceps 
and hamstring 
strength were 
above 90% LSI.  
 
At Baseline: 
subjects who 
were older, 
performed 
better on the 
triple crossover 
and 6-m time 
hop, and had 
better IKDC 
2000 scores 
opted to go 
through with 
non-operative 
treatment.                                
1 Year Follow 
up:  Non-
77% of 
children 
remained ACL 
deficient 
throughout 2 
years. 91% of 
ACL deficient 
children 
continued to 
participate in 
pivoting sports. 
IKDC 2000 
had a mean 
score of 82.7 at 
baseline and 
increased to an 
Isokinetic 
muscle 
strength of 
both the 
hamstring and 
quadriceps 
muscle groups 
were at or 
above an LSI 
value of 90%. 
There was no 
significant 
group by time 
change 
throughout the 
course of the 
23 
 
operative group 
preformed 
significantly 
better on the 
single and triple 
hop tests. ACL-
r group had 
significantly 
higher IKDC 
2000   
 
82.9 at 2 year 
follow up. Did 
not show a 
significant 
increase in 
value over the 
course of the 
study. All 
single legged 
hop test above 
90% LSI at 
baseline. There 
was a 
significant 
change in 
Single and 6 m 
timed. At 
baseline both 
quadriceps and 
hamstring LSI 
strength 
measurements 
were above 
90%. No 
significant 
change in 
either over 2 
years 
 
study. IKDC 
scores 
increased 
throughout the 
2-year study, 
again 
however, there 
was not a 
significant 
group by time 
relationship.  
 
Level of 
Evidence 
 
2b According to 
the Oxford 
Centre for 
Evidence-Based 
Medicine 
taxonomy. 
 
2b According to 
the Oxford 
Centre for 
Evidence-Based 
Medicine 
taxonomy. 
 
2b According 
to the Oxford 
Centre for 
Evidence-
Based 
Medicine 
taxonomy. 
 
2b According 
to the Oxford 
Centre for 
Evidence-
Based 
Medicine 
taxonomy. 
 
Validity 
Score 
 
18/22 
 
17/22 
 
17/22 
 
 
21/22 
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Conclusion 
 
At two years 
after ACL 
injury, ACL 
deficient 
patients had 
adequate knee 
function.  
 
A majority of 
the individuals 
who were 
treated with a 
conservative 
treatment 
algorithm were 
able to return to 
pre-injury 
activity level. In 
addition, when 
compared to 
individuals who 
underwent 
ACL-r, non-
operative 
subjects had 
similar 
performance-
based outcome 
measures. 
 
Majority of 
children 
remained ACL 
deficient and 
had adequate 
knee function.  
 
At 2-years 
post-injury, 
the non-
surgically 
treated group 
had LSI values 
>90 for both 
knee extension 
and flexion. 
The IKDC-
2000 scores 
improved over 
2 years.  
 
 
 
 
 
 
 
Figure 2.1 Summary of Search History and Included Studies 
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CHAPTER 3. ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION REINITIATES AN 
INFLAMMATORY AND CHONDRODEGENERATIVE PROCESS IN THE KNEE JOINT 
Abstract  
 Anterior cruciate ligament (ACL) injury leads to a sustained increase in synovial fluid 
concentrations of inflammatory cytokines and biomarkers of cartilage breakdown. While 
this has been documented post-injury, it remains unclear whether ACL reconstruction 
surgery contributes to the inflammatory process and/or cartilage breakdown. This study is 
a secondary analysis of 14 patients (9 males/5 females, mean age=19, mean BMI=28) 
enrolled in an IRB-approved randomized clinical trial. Arthrocentesis was performed at 
initial presentation (mean=6 days post-injury), immediately prior to surgery (mean=23 
days post-injury), one-week post-surgery, and one-month post-surgery. ELISA kits were 
used to determine concentrations of C-telopeptide fragments of type II collagen (CTXII), 
IL-6 and IL-1b in the synovial fluid. The log transformed IL-1b was not normally 
distributed; therefore, changes between time points were evaluated using a non-
parametric Kruskal-Wallis one-way ANOVA. IL-1b concentrations significantly 
increased from the day of surgery to the first postoperative time point (p<.001) and 
significantly decreased at the 4-week postoperative visit (p=.03). IL-1b concentrations at 
the 4-week postoperative visit remained significantly greater than both preoperative time 
points (p >.05). IL-6 concentrations at 1 week post-surgery were significantly higher than 
at initial presentation (p=0.013), the day of surgery (p<0.001), and 4 weeks after surgery 
(p=0.002).  CTX-II concentrations did not differ between the first three time points 
(p>.99) but significantly increased at 4 weeks post-surgery (p<.01). ACL reconstruction 
appears to reinitiate an inflammatory response followed by an increase in markers for 
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cartilage degradation. ACL reconstruction appears to initiate a second “inflammatory hit” 
resulting in increased chondral breakdown suggesting that post-operative 
chondroprotection may be needed.   
Introduction  
Anterior cruciate ligament (ACL) injury is one of the most prevalent 
musculoskeletal injuries affecting young athletic populations with an incidence of 
200,000 persons per year.69 Post traumatic osteoarthritis (PTOA) is an unfortunate 
consequence of ACL injury, with 50%-60% of patients exhibiting detectable radiographic 
changes consistent with osteoarthritis (OA) as early as 5 years and clinical symptoms of 
OA within ten years following the injury.70,71 Previous72,73 studies have indicated that 
ACL rupture begins a deleterious cascade of events that include an increase in 
inflammatory cytokines and collagen breakdown markers within the joint following 
injury.9,11-14,74-76  
In the United States of America, the overwhelming majority of patients with ACL 
injuries undergo ACL reconstruction.  The primary goal of ACL reconstruction is to 
reestablish joint stability to allow patients to return to their previous level of function.77  
Furthermore, reestablishing tibio-femoral kinematics with surgery has the potential to 
diminish subsequent cartilage damage;78 however, patients often exhibit signs and 
symptoms of PTOA within 10 years of injury regardless of whether or not they undergo 
reconstruction.79  Recent data from a large randomized clinical trial investigating surgical 
versus non-surgical or delayed surgical treatment of ACL injured patients has raised the 
concern that ACL reconstruction leads to an increase in inflammatory makers compared 
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to patients that did not undergo surgery. This second “inflammatory hit” has not been 
confirmed to date.21  
The purpose of this study was to assess inflammatory and cartilage biomarkers 
before and after ACL reconstruction to determine if surgery results in a secondary 
inflammatory response. We hypothesized that markers of inflammation (interleukin-1b, 
(IL-1b), interleukin-6 (IL-6)) would be significantly increased following ACL 
reconstruction surgery. 
Methods 
3.1.1 Patients  
Patients with primary ACL injury consented to enrollment in an IRB-approved 
randomized clinical trial assessing the use of hyaluronate injection versus placebo one 
week post reconstruction (clinicaltrials.gov: NCT03429140).  There were no 
postoperative differences between the placebo and hyaluronate groups in terms of 
cartilage or inflammatory biomarkers, allowing groups to be collapsed for the current 
analysis. Patients were enrolled within the first 10 days following ACL injury. To be 
included in this study, patients had to have an isolated ACL tear with no concurrent PCL 
injury and could not have a grade 3 or higher MCL or LCL injury. Patients were between 
the ages of 14 and 32 and were skeletally mature with closed knee growth plates verified 
via radiograph. They had to have no history of previous surgery on the ipsilateral or 
contralateral knee and their ACL injury had to occur during sports activity. Exclusion 
criteria included the ACL injury occurring more than 10 days prior to enrollment, 
previous ipsilateral or contralateral knee surgery, intra-articular cortisone injection into 
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either knee within 3 months of injury, and a history of any inflammatory disease (Figure 
3.1).  
3.1.2 Study Design  
The current study is a secondary analysis of the previously mentioned randomized trial. 
Arthrocentesis was performed on the day of initial presentation (mean = 6 days post 
injury), and all patients received a triamcinolone acetonide (Kenalog 40mg) injection at 
the time of initial presentation to dampen the inflammatory response.12 On the day of 
ACL reconstruction all patients received a knee aspiration (mean = 23 days post injury), 
before the surgical procedures began. One week post-operatively patients received a knee 
aspiration, were randomized and received an injection of either hyaluronate (Gel-OneÒ, 
Zimmer Biomet, Warsaw, IN) or saline. Four weeks post reconstruction all patients 
received a final knee aspiration. Synovial fluid was aspirated and immediately 
centrifuged at 3,500 rpm for 10 minutes. The supernatant was collected, aliquoted and 
stored at -80°C for further analysis.  
3.1.3 Biomarker Assays  
Synovial fluid biomarkers were assessed using commercially available enzyme linked  
immunosorbent assays (ELISA). Assays were run in duplicate, any samples outside of the 
limits of detection or quantification were rerun and intra-assay coefficients of variance 
were less than 9.5 for all plates. Biomarkers analyzed to assess inflammation included 
interleukin one beta (IL-1b) and IL-6 (Meso Scale Discovery). The biomarkers utilized in 
the current study follow the recommendations made by the OARSI, Arthritis Research 
UK Osteoarthritis, and Crystal Disease Clinical Study Group Expert Working Group.80-82 
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3.1.4 Statistical Analysis 
Statistical analysis was completed using Sigmaplot v14 software. Data that were not 
normally distributed were log transformed.83 For data points that were below the lowest 
limit of detection, the manufacturer-provided LLOD value was halved and used for 
computation.84 A one-way repeated measures ANOVA was performed to determine 
differences between time points. The log transformed IL-1b was not normally distributed; 
therefore, changes between time points were determined using a non-parametric Kruskal-
Wallis one-way ANOVA. A Holm-Sidak test was utilized for paired comparisons.  
Statistical significance was set as P <.05. 
Results  
Fourteen patients (9 males and 5 females, mean age= 19 ± 2.6, mean BMI= 28 ± 
5.0) were included in these analyses. Twelve of the 14 (86%) patients presented with 
meniscus pathology that was addressed in surgery (Table 3.1).   
 IL-1b concentrations one week post-surgery (from 0.04 ± 0.05 to 0.99 ± 1.22 
pg/mL) were significantly greater than initial presentation 6 days post-injury (p=0.015) 
and were also significantly greater than the day of surgery (p<0.001). By 4 weeks post-
reconstruction IL-1b concentrations decreased but did not return back to day of surgery 
levels (p=0.001). There was a significant decrease in IL-6 from the time of initial 
presentation to surgery (p<0.001). IL-6 concentrations at 1 week post-surgery were 
significantly greater than initial presentation (2.06 ± 5.10 to 1427.68 ± 920.62 pg/mL, 
p=0.013), the day of surgery (p<0.001), and 4 weeks after surgery (p=0.002). Four weeks 
31 
 
post operatively, IL-6 concentrations remained significantly higher than the day of 
surgery (p<0.001, Figure 3.2). 
Discussion  
The results of this study support the theory that ACL reconstruction represents a “second 
hit” to the injured knee joint. There is a well-documented elevation in inflammatory and 
cartilage breakdown markers in synovial fluid following ACL injury.9,11,13,74,85 Despite 
preoperative administration of intraarticular Triamcinolone acetonide, pro-inflammatory 
cytokines concentrations were significantly increased in the synovial fluid following 
ACL reconstruction.  Furthermore, cytokine concentrations one week after surgery were 
greater than what was observed approximately one week after the initial insult of injury.12 
Our findings concur with previous findings of an increased inflammatory burden 
following ACL reconstruction.86  
The findings from this study establish the early time frame during which the 
inflammatory process occurs. Joint inflammation after ACL reconstruction increases 
immediately after surgery, and while pro-inflammatory cytokine concentrations begin to 
reduce 4 weeks after surgery, they do not return to normal preoperative levels. Larsson et 
al. found similar results, showing an increase in synovial fluid pro-inflammatory 
cytokines up to 5 years post reconstruction, when compared to patients who had delayed 
reconstruction.87 Consequently, this suggests that the elevations in IL-1b and IL-6 seen in 
some of our patients may not return to normal for 5 years or longer. Interestingly, the 
increase in chondral breakdown markers does not increase until 4 weeks or longer after 
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the ACL reconstruction.12,88 This may suggest a time-related response of chondral 
breakdown to the second  “inflammatory  hit”.  
 A state of increased and/or prolonged inflammation could contribute to 
chondrodegenerative and bony changes observed in the first two years ACL 
reconstruction thereby promoting the progression of PTOA. Chronic inflammatory 
synovitis89,90 and several pro-inflammatory cytokines, most notably IL-1 and TNFa91,92, 
have been closely linked to the progression of idiopathic OA. Furthermore, data from 
animal studies emphasize the role of IL-1 and TNFa in the onset and progression of 
OA,93 similarly pro-inflammatory stimulation of meniscus cells increases cytokine and 
matrix metalloproteinase (MMP) activity.94  
ACL reconstruction is a clinically successful procedure with patients reporting 
improved outcomes 10 years following surgery.95 While ACL reconstruction successfully 
restores joint stability, the biologic response to injury and subsequent surgery are not 
sufficiently addressed by current approaches. Chronic posttraumatic inflammation and 
seemingly related progressive chondral degradation should likely be addressed. Hence, 
the treatment paradigm may need to be shifted to include treatments to address 
inflammation outside of the immediate healing response window as described by 
Anderson et al.96  
There is evidence that biologic agents targeting the inflammatory process can 
reduce inflammation and can potentially mitigate the early process of 
chondrodegradation. For example, IL-1ra can reduce chondral lesion size and improve 
outcomes in animal models and in an idiopathic OA population.97,98, 99  In a small 
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randomized clinical trial IL-1ra has been shown to redcue pain and effusions after ACL 
reconstruction.100 Our group has reported that intraarticular administration of 40 mg of 
triamcinolone acetonide successfully alters the progressive increase in CTXII as marker 
of cartilage degradation 4 weeks after ACL injury.12 In addition biologics such as platelet 
rich plasma (PRP) and even more so, bone marrow aspirate concentrate (BMAC) have 
been shown to contain an abundance of IL-ra and other anti-inflammatory cytokines and 
could potentially be treatment options that need to be considered.101,102 Other potential 
interventions that aim at reducing MMP and cytokine activity after acute knee injury may 
alter the progression of PTOA,103 suggesting that perioperative anti-inflammatory 
treatment may improve joint health following surgery.  
 Other modifiable factors to potentially mitigate the progression of PTOA could 
include the timing of surgery and/or surgical technique. Traditionally, early 
reconstruction was contraindicated due to the risk for the development of 
arthrofibrosis.104 However, more recent literature suggests that earlier timing of ACL 
reconstruction with early aggressive rehabilitation is not detrimental to the joint, and 
outcomes following early surgery are consistent with those undergoing more traditional 
surgical timing.21,105 Eriksson et. al21, suggested that early surgery may combine the 
traumas of the initial injury and surgery. This would avoid a “second hit” to the joint21 
potentially avoiding the re-initiation of the cartilage breakdown process. Along with the 
timing of surgery, additional studies are necessary to determine if less invasive surgical 
approaches like bridge-enhanced ACL repair106 or “biologic ACL repair” lessens the 
magnitude of the “second hit” when compared to conventional ACL reconstruction.  
34 
 
 This pilot study is not without limitations. As this was a pilot study, the results 
should be used for hypothesis generation and these preliminary results do not meet the 
rigor necessary to modify the standard of care. However, the results of this study inform 
us that fully-powered RCTs examining pre- and/or postoperative anti-inflammtory or 
chondroprotective interventions are needed. As such, additional studies are necessary to 
verify our findings and to develop evidence-based approaches to potentially offset the 
postoperative inflammatory cascade and cartilage degradation. Second, the purpose of 
these analyses was to assess inflammatory and cartilage biomarkers during the first 
postoperative month, long term follow-up will be necessary to determine if the elevated 
levels of proinflammatory and chondrodegenerative biomarkers persist after ACL 
reconstruction and contribute to the progression of PTOA. This will be done in the future 
as we are following this cohort of patients prospectively. Third, this well controlled pilot 
study included relatively little variation in terms of the timing of surgery (average 23 
days post injury). Additional studies are necessary to assess whether the timing of ACL 
reconstruction – either acute or delayed – may dampen the postoperative inflammation 
and cartilage degradation.  
Conclusion  
ACL injury leads to an initial inflammatory response that begins to subside over 
the first several weeks after injury but is associated with chondral degradation. ACL 
reconstruction within 3-4 weeks after ACL injury reinitiates both the inflammatory 
response and subsequent cartilage degradation. Even with an anti-inflammatory treatment 
administered post injury, this “second hit” to the joint was associated with both a larger 
and more prolonged inflammatory response than the initial injury itself.  This insight 
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suggests that an early post-injury and/or postoperative intervention addressing prolonged 
inflammation and associated chondral degradation may be needed in order to potentially 
alter the progression of PTOA after ACL injury. 
These results represent a critical step in understanding the complex interplay 
between inflammation and cartilage breakdown following ACL reconstruction. We have 
shown the progression of inflammatory biomarkers, both in response to the initial ACL 
injury and after reconstruction. This provides insights into the timing of when anti-
inflammatory interventions could be most meaningfully applied. Further research is 
necessary to explore treatment options that are both effective in reducing the 
inflammatory response and cartilage breakdown to promote long-term joint health. 
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Table 3.1 Meniscus pathology addressed at the time of ACL reconstruction  
 Medial Lateral  
No meniscus involvement 2 (14%) 2 (14%)  
Meniscus Repair 6 (43%) 5 (29%)  
Meniscectomy 1 (7%) 3 (21%)  
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Figure 3.1 CONSORT enrollment flow chart.  
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Figure 3.2 Inflammatory progression of IL-1b and IL-6 after ACL injury and 
reconstruction.  
IL-1b concentrations significantly increased one week post-surgery when compared to 
initial presentation (p=0.015) and the day of surgery (p<0.001)(2). Four weeks post-
reconstruction IL-1b concentrations decreased but did not return back to day of surgery 
levels (p=0.001)(1). There was a significant decrease in IL-6 from the time of initial 
presentation to surgery (p<0.001)(a). IL-6 concentrations at 1 week post-surgery were 
significantly greater than initial presentation (p=0.013), the day of surgery (p<0.001), and 
4 weeks after surgery (p=0.002)(b). Four weeks post operatively, IL-6 concentrations 
remained significantly higher than the day of surgery (p<0.001)(a) 
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CHAPTER 4. UPREGULATION OF SYSTEMIC INFLAMMATORY PATHWAYS FOLLOWING 
ANTERIOR CRUCIATE LIGAMENT INJURY RELATE TO BOTH CARTILAGE AND MUSCULAR 
CHANGES: A PILOT STUDY  
Abstract  
In conjunction with cartilage breakdown, muscle maladaptation including atrophy 
and increased fibrosis have been observed in the quadriceps following anterior cruciate 
ligament (ACL) injury. Previously observed upregulated muscle-related proteins in the 
synovial fluid following ACL rupture allude to cellular communication between the joint 
and muscle. Therefore, the purpose of this study was to determine whether muscle-related 
analytes are differentially expressed in the serum. Sixteen patients with an acute ACL 
tear participated in this IRB-approved study. Serum was obtained at two different time 
points at a mean 6 and 14 days post injury, and serum was analyzed by a highly 
multiplexed assay of 1300 proteins. Pathway analysis using DAVID was performed; 
genes included met three criteria: significant change between the 2 study time points 
using a paired t-test, significant change between the 2 study time points using a Mann 
Whitney non-parametric test, and significant Benjamini post hoc analysis. Twelve 
analytes significantly increased between time points. Proteins chitinase-3-like protein 1 
(p= .01), insulin-like growth factor binding protein 1 (p= .01), insulin-like growth factor 
binding protein 5 (p= .02), renin (p=.004) and lymphotoxin alpha1: beta2 (p= .03) were 
significantly upregulated in serum following acute ACL injury. The current results 
confirm the inflammatory pattern previously seen in the synovial fluid thought to play a 
role in the progression of post traumatic osteoarthritis after ACL injury, and this data also 
provides further insights into important communication between the joint and quadriceps 
group, whose function is important in long term health.  
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Full Reference: Hunt, E. R., Villasanta‐Tezanos, A. G., Butterfield, T. A., Lattermann, 
C., & Jacobs, C. A. (2020). Upregulation of Systemic Inflammatory Pathways Following 
Anterior Cruciate Ligament Injury Relates to Both Cartilage and Muscular Changes: A 
Pilot Study. Journal of Orthopaedic Research®, 38(2), 387-392. 
Introduction  
Traumatic anterior cruciate ligament (ACL) injury causes a deleterious cascade of 
events including a robust inflammatory response and cartilage breakdown characterized 
by increases in markers of cytokines and collagen catabolism that could lead to 
chondrocyte death.8,12,74,75,107,108  Along with increased pro-inflammatory markers and 
cartilage breakdown another hallmark of ACL injury is persistent long-term quadriceps 
atrophy. Atrophy and weakness of this muscle group continues long after injury and even 
surgical intervention, causing the joint to remain unstable due to a lack of strong dynamic 
stabilization.1,3  
Changes in quadriceps morphology post-injury suggest that acute ACL injury 
affects not only the local environment within the synovial joint but the surrounding 
structures as well. Following injury, the quadriceps muscle shows increased fibrosis, 
decreased  satellite cell number,30,31 and a decreased fiber cross sectional area indicating 
atrophy.  Furthermore, after ACL reconstruction, there are upregulations in common 
muscle growth regulators including myostatin35 a widely studied signaling molecule of 
the transforming growth factor-beta superfamily that induces atrophy by activating the 
ubiquitin proteasome pathway (UPP).35 What remains unknown is the effect of the 
inflammatory process on the quadriceps and its influence on changes in muscle. The 
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differential muscle morphology post injury is relevant because it lends evidence that the 
joint and muscle may communicate cellularly. This cross-talk between systems could be 
contributing to the persistent atrophy seen clinically and therefore may identify proteins 
vital to the interplay between the inflamed joint and quadriceps muscle.  
Previously, a study looking at the proteomic response in the synovial fluid to ACL 
injury revealed upregulated muscle related analytes after injury.11 Muscle-related analytes 
myoglobin and SMAD 2/3 are linked to muscle stress and cell growth, but were an 
unexpected finding in the synovial fluid following acute ACL injury. Therefore, the 
purpose of this study was to determine whether muscle-related analytes are differentially 
expressed in the serum. We hypothesized that proteins related to muscle would be 
increased in the serum after ACL injury, providing a means of transport to the synovial 
fluid. 
Methods  
4.1.1 Study Design  
This study represents a secondary analysis of samples collected as part of a 
randomized clinical trial of patients with acute ACL rupture (clinicaltrials.gov: 
NCT01692756). This RCT aimed to determine the effectiveness of early anti-
inflammatory treatment post ACL injury. 12 While the aim of this RCT was to determine 
the effect of intra-articular triamcinolone acetonide, none of the patients included in this 
subgroup analysis received a corticosteroid injection at either of the time points used in 
the current analyses. Subjects included in this proteomic analysis were a part of the 
placebo group who underwent blood collections via venipuncture, arthrocentesis and 
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intra-articular saline injections (10 mL). Blood collection was performed on the day of 
initial presentation (mean= 6 days post-injury, range = 2-8 days) and again between 6 and 
12 days after initial presentation (mean=14 days post-injury, range = 8-20 days).  
4.1.2 Patient Demographics  
This study consisted of 16 patients (8 females, 8 males; mean age 18 years, range 
15-26 years; mean body mass index 23, range 18-28 kg/m2) with acute ACL rupture. 
Inclusion criteria were as follows: isolated ACL injury determined by clinical exam 
(positive Lachman test with intra-articular effusion) that was corroborated using magnetic 
resonance imaging (MRI); age 14 years or older; skeletally mature with closed growth 
plates visualized by radiograph; no history of ipsilateral knee injury; ACL injury had to 
occur during sports activities; no clinical evidence of posterior cruciate ligament 
involvement; and no more than a grade 1 medial or lateral collateral ligament injury. 
Exclusion criteria were: injury occurrence more than eight days before enrollment; 
previous knee surgery; history of intra-articular cortisone injection into either knee within 
three months of injury; or history of any inflammatory disorder.  
 ACL tear was confirmed intraoperatively at the time of reconstruction and pre-
operative MRI ensured there were no concomitant ligamentous injuries. Patients were 
instructed to avoid any prescription or over the counter anti-inflammatory medications 
but were allowed to use rest and ice to manually control swelling. All patients received 
the same rehabilitation protocols which included home based exercises focused on range 
of motion and quadriceps muscle activation.109  
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4.1.3 Proteomic Analyses 
Similar to analyses previously performed on synovial fluid samples,11 serum 
samples were collected for proteomic analysis with a high throughput and highly 
multiplexed assay (SOMAscan version 3, SomaLogic, Inc., Boulder, CO). The technique 
uses aptamers, chemically modified oligonucleotides that recognize the 3-dimensional 
structure of proteins with high specificity and high sensitivity. Each aptamer is tagged 
with a  DNA sequence enabling quantification using a hybridization array. The assay 
converts the measurement of proteins into the measurement of corresponding DNA. Data 
are recorded for each of the 1317 proteins as relative fluorescent units (RFU). The 
coefficient of variation for the SOMAscan Assay is 5% (somalogic.com/somascan-assay-
faqs).   
4.1.4 Statistical Analysis 
Paired t-tests were used to determine differences between biomarker levels at the 
two preoperative time points for each analyte. Due to the small sample size, standardized 
response means (SRMs) were also calculated to potentially identify any trends within the 
data. SRM is the pre- to post change divided by the standard deviation of the change 
scores for that particular variable, and values of >0.8 are considered large.110,111 In 
general, higher values of these proteins would reflect a state of greater inflammatory 
response and a potential propensity for osteoarthritic changes and progression. We also 
included an exploratory group of five analytes previously found to be upregulated in the 
synovial fluid that are related to skeletal muscle (myoglobin, SMAD 2/3, CDON, and 
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fibronectin), three related to inflammation (IL-1b, TGFb and TNFa) and one related to 
cartilage breakdown (MMP-1).11  
 The Database for Annotation, Visualization and Integrated Discovery (DAVID 
Bioinformatics Resources, National Institute of Allergy and Infectious Diseases, NIH) 
was used to complete the pathway analysis. To be included in the post-hoc pathway 
analysis, genes had to pass three different statistical tests. All of the genes had to have a 
significant change between the two study time points using a paired t-test, a significant 
change between time points using a Mann-Whitney nonparametric test and significant 
Benjamini post hoc analysis. Upregulated pathways were identified using The Gene 
Functional Analysis Tool, with Benjamini post hoc analyses to account for multiple 
comparisons.112,113 Non-parametric Spearman correlations were used to determine 
potential relationships between analytes that were significantly upregulated and a known 
marker of cartilage breakdown (MMP-1). Prior to running the correlations, a Grubbs test 
for outliers was used to determine the presence of any outliers within the data set. Alpha 
was set at 0.05 a priori.  
Results  
4.1.5 Analytes with Largest Increase 
There were 1,317 analytes measured in total.11 Of those, 12 demonstrated the 
largest changes in the serum within the first two weeks after injury (Table 3.1). Even with 
a small sample size, moderate to large changes in analyte concentrations between time 
points (SRM ranges -0.58 to 0.69) were observed. There were five analytes that 
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significantly increased in concentration in the serum within the first two weeks after ACL 
injury and seven that significantly decreased (p<0.05).  
A Grubbs test revealed one outlier within the MMP-1 group (p<0.05), therefore 
that subject was excluded from the correlation. There was a moderate correlation (rho 
=0.64, p = 0.009) between the initial serum levels of Matrix Metallopeptidase 1 (MMP-1) 
and the change in Insulin Like Growth Factor Binding Protein 5 (IGFBP-5; Figure 3.1).  
4.1.6 Pathway Analysis 
Four distinct pathways were identified using DAVID analysis. These include 
complement and coagulation cascades (p=0.003, three analytes identified in this 
pathway), NF-κβ signaling pathway (p=0.004, three analytes identified), platelet 
activation (p=0.009, three analytes identified) and ghrelin (p=0.05, two analytes 
identified). Analytes associated with each specific pathway can be found in Table 3.2.  
4.1.7 Analytes Previously Linked to Skeletal Muscle and Inflammation  
There were no significant changes in any of the muscle related analytes, 
inflammatory, or cartilage breakdown markers (Table 3.3). Of these analytes, fibronectin, 
myoglobin, MMP-1 and IL-1β  were decreased whereas the others increased between the 
two study time points, but not enough to be significant. 
Discussion  
The purpose of this study was to determine whether muscle-related analytes are 
differentially expressed in the serum.11 This would provide a potential mechanism of 
communication by which proteins may travel to the joint and influence the systemic 
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environment. In a mouse model of knee OA, increases in inflammatory markers in the 
serum preceded increases in IGFBP-5 in the muscle and subsequent muscle wasting.114 
Similarly, acute ACL injury initiates a biochemical cascade with increased pro-
inflammatory cytokines and increased markers of cartilage breakdown within the joint.12 
Castillero also found increases in inflammatory markers in the serum that preceded 
increases in IGFBP-5 in the muscle.114  The muscle related analytes previously found in 
the synovial fluid11 were not significantly increased in the serum in the current study, 
possibly because they are downstream in the signaling pathways. However, IGFBP-5 was 
elevated in the serum which may have implications for the long-term changes seen within 
the quadriceps muscle.   
4.1.8 Intra-articular Inflammation and Upregulation of IGFBP-5 
IGFBP-5 may have important implications for skeletal muscle atrophy after ACL 
injury. Insulin growth factor (IGF) has important functions throughout the body but most 
importantly, in this context, it is a potent skeletal muscle growth mediator115 and may 
regulate cartilage matrix synthesis.116 Insulin like binding proteins (IGFBPs) regulate the 
function of IGF and IGFBP-5  specifically mediates  skeletal muscle differentiation and 
possibly hypertrophy.115,117,118 IGFBP-5 is the predominatant growth factor binding 
protein expressed in muscle119 and can regulate IGF by binding to it with an affinity as 
high as binding with the IGF receptor. This then allows the binding proteins to influence 
IGFs115, either by altering IGF actions117 or by switching on IGF-II.120 The regulation of 
IGFBP-5 is more elusive but studies point to regulation by key micro RNAs121 like miR-
140.122  
47 
 
The current study focused on the proteomic analysis after acute ACL injury but 
there has been some research investigating the role of IGFBP-5 on skeletal muscle and 
cartilage in induced OA models. Microarray analysis in rats with monoiodoacetate 
induced OA showed upregulated gene clusters related to skeletal muscle development 
and specifically increases in IGFBP-5 in animals with cartilage damage.123 Rats with 
induced arthritis had significant upregulations in MuRF1, indicating muscle catabolism, 
in conjunction with increased levels of IGFBP-5 in the gastrocnemius muscle.124 Induced 
arthritis via adjuvant injection also showed significant increases in gastrocnemius 
IGFBP-5 two weeks after injection as well as a significant decrease in gastrocnemius 
muscle mass and serum IGF-1. Olney et al., found that chondrocytes from osteoarthritic 
knees had increased expression of IGFBP-5116, theorizing it may play a role in cartilage 
breakdown. Our data support this finding and demonstrated a strong correlation between 
patient’s initial levels of MMP-1, a cartilage breakdown marker, and changes in IGFBP-5 
(Figure 3.1). These positive correlations suggest a complex communication network that 
is triggered by intraarticular inflammation and cartilage changes which then result in 
increased systemic inflammatory markers and finally changes in skeletal muscle.   
4.1.9 IGFBP-5 and Muscle Atrophy  
In animal models, elevated IGFBP-5 and inhibition of IGF has been consistently 
associated with atrophy. Stevenson et al. in 2003 found that in atrophied rat soleus 
IGFBP-5 was elevated four-fold by day four of hindlimb unloading and remained 
elevated at 14 days.125 In a study of mouse muscle overload and atrophy, researchers 
found that the soleus muscle was atrophied by 20% after eight days of unloading, with a 
two-fold increase in IGFBP-5 and a decrease in IGF-1 mRNA. After eight days of 
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overload, IGFBP-5 mRNA remained significantly lower in overloaded skeletal muscle 
than control muscles.126 Furthermore, overexpression of IGFBP-5 in a mouse model 
resulted in reduced muscle fiber hypertrophy as well as an overall lower body mass 
compared to control animals.118 Steves et al. demonstrated that the tibialis anterior 
muscles did not grow as expected following reloading after atrophy in IGF over-
expressing mice, and reported significantly elevated IGFBP-5 levels three  weeks after 
re-ambulation.127  
Although quantifying muscle tissue specific  IGFBP-5 levels was beyond the 
scope of this study, our results suggest that IGFBP-5 may be systemically upregulated in 
first two weeks after ACL injury. Circulating levels of IGFBP-5 presents a potential link 
between traumatic joint injury and quadriceps atrophy. This finding uncovers an 
interesting avenue for further investigation of the potential inhibition of IGF in the 
quadriceps by IGFBP-5 leading to the quadriceps atrophy seen clinically. There are many 
studies looking at the effects of IGFBP-5 in disuse atrophy and transgenic 
knockout,118,120,126,127 but there is little evidence on its effects after traumatic joint injury. 
A more in-depth exploration into the communication between IGF and IGFBP-5 post 
ACL injury would be necessary to define its effects on both the joint and musculature. In 
addition, future studies are necessary to determine if systemic changes in IGFBP-5 also 
result in changes to not only the quadriceps but other muscle groups as well (hamstrings, 
gastrocnemius, etc.).  
4.1.10 Differences Between Serum and Synovial Fluid Proteomics  
Proteomic changes in the serum did not mimic changes in synovial fluid reported 
previously, revealing fewer and much different analytes and upregulated pathways. While 
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this was not expected, the upregulated analytes in the serum related to either clotting or 
inflammation with the exception of the insulin-like growth factor binding proteins. 
Pathways including complement and coagulation and platelet activation are to be 
expected due to hemarthrosis into the knee joint after injury.128 ACL injury creates an 
influx of pro-inflammatory markers, protein mediators and blood into the joint, which 
may perpetuate the cartilage damage.129 Since synovial fluid is an “ultrafiltrate” of 
plasma and not a static protein pool,130 contents continuously filter in and out of the joint. 
Under healthy conditions, there is flow of synovial fluid over the synovial interstitial 
space that turns over allowing in and out flux of transudate. During periods of trauma the 
transudate becomes exudate, a protein filled fluid that resides extracellularly in the 
synovium.130  
After ACL injury in particular, the length of time that hyaluronan is present in the 
joint decreases suggesting that there is a transport system for altered synovial fluid post 
injury.131 Moreover, the molecular sieve theory postulates that hyaluronan chain length 
filters the synovial fluid only allowing molecules between 33-59 nm into the articular 
space132, thus only allowing certain proteins to flow back and forth. Synovial fluid 
filtration post injury may be a possible explanation as to why the analytes that were 
upregulated after injury in the synovial fluid were not the same as those upregulated in 
the serum. Persistent muscular dysfunction after ACL injury is undoubtedly a complex, 
multifactorial injury but better understanding the communication between the intra- and 
extraarticular environments is important in identifying the underlying mechanisms and 
potential treatment targets.  
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4.1.11 Limitations  
This pilot study of the proteomic response to ACL injury in human serum is not 
without limitations, particularly that an a priori power analysis was not used for sample 
size. This study included 16 subjects following acute, isolated ACL injury, which limits 
conclusions that can be drawn and if these results are generalizable to other populations. 
The progression of inflammation following ACL injury is multifaceted and previous 
studies show that variables like body mass index, sex and age all effect this 
progression133, and should be included in further analysis. These data provide insight into 
the systemic response after ACL injury and indicate that the effect in serum differs from 
that in synovial fluid. The present study used samples from two early time points after 
injury but demonstrates that proteomic analysis can be valuable in determining potential 
communicating factors between the intra- and extraarticular environments after ACL 
injury. Future studies focused on the influence of inflammatory and skeletal muscle 
markers on cartilage is necessary to determine the interplay between the local joint 
environment and surrounding structures.  
Conclusions  
ACL injury affects not only the knee joint but the surrounding musculature as 
well. The current proteomic analyses identified analytes that could have implications for 
inflammation, muscle atrophy, and cartilage health. The proteomic analysis of the serum 
provided insight into systemically upregulated analytes that could be important for 
communication between the inflamed joint and subsequent changes in muscle. 
Identifying key players in the communication between the intra- and extraarticular 
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environments will be crucial to developing successful interventions for the prevention of 
muscle atrophy and cartilage breakdown. Further investigations will be necessary to 
elucidate the relationship of analytes like IGFBP-5, inflammation, and muscular changes 
after ACL injury.  
 
Table 4.1  Twelve analytes that were significantly up or down regulated between the time 
of ACL injury and one-week post injury. 
 All values are expressed in relative fluorescent units (RFU; mean ± standard deviation). 
Protein Time 1 Time 2 P SRM 
Chitinase-3-like protein 1  5468.9 ± 3369.2 8102.8 ± 6508.8 0.015 0.69 
Insulin-like growth factor-binding 
protein 5 
1697.6 ± 323.04 1992.9 ± 531.9 0.015 0.69 
Insulin-like growth factor- binding 
protein 1 
659.6 ± 389.9 1070.6 ± 816.6 0.030 0.60 
Renin 368.0 ± 109.6 435.1 ± 96.3 0.032 0.59 
Lymphotoxin alpha1: beta2 193.2 ± 52.8 238.3 ± 96.7 0.038 0.57 
Cathepsin Z 3006.1 ± 751.1 2497.4 ± 778.8 0.034 -0.58 
Fibrinogen 32497.3 ± 12149.5 25956.5 ± 7428.3 0.024 -0.63 
Carbonic anhydrase 6 10018.4 ± 4794.5 8828.9 ± 4425.8 0.005 -0.63 
Fibrinogen gamma chain 7449.6 ± 2530.2 5850.8 ± 1547.8 0.020 -0.65 
Lipopolysaccharide-binding protein  45316.3 ± 10568.0 36271.2 ± 12465.6 0.015 -0.69 
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Table 4.1(continued) 
 
C-reactive protein 11677.4 ± 12578.4 5246.2 ± 6217.1 0.012 -0.71 
Parathyroid hormone 1169.3 ± 317.3 961.7 ± 226.7 0.007 -0.79 
 
 
 Table 4.2  Analytes identified for each of the significant pathways 
Pathway Analytes 
Complement and coagulation cascades  Fibrinogen alpha chain (FGA) 
Fibrinogen beta chain (FGB) 
Fibrinogen gamma chain (FGG) 
NF-kappaβ Lipopolysaccharide binding protein (LBP) 
Lymphotoxin alpha (LTA) 
Lymphotoxin beta (LTB) 
Platelet activation  Fibrinogen alpha chain (FGA) 
Fibrinogen beta chain (FGB) 
Fibrinogen gamma chain (FGG) 
Ghrelin Insulin like growth factor binding protein 1 (IGFBP1) 
Insulin like growth factor binding protein 5 (IGFBP5) 
 
 
 
 
 
 
 
53 
 
Table 4.3  Muscle, inflammatory and cartilage related analytes between the time of injury 
and one-week post injury. 
All values are expressed in relative fluorescent units (RFU; mean ± standard deviation). 
 
 
 
 
 
 
Muscle Related Analytes  Time 1 Time 2 P SRM 
Cell adhesion molecule-
related/down-regulated by 
oncogenes 
5028.8 ± 1293.7 
 
 
5240.1 ± 1323.0 
 
 
0.42 0.21 
Fibronectin 11152.4 ± 
4289.1 
 
 
8621.0 ±  5605.3 
 
 
0.15 -.38 
Myoglobin  1046.1 ± 368.8 
 
 
889.1 ± 405.5 
 
 
0.31 -0.26 
Mothers against decapentaplegic 
homolog 2  
983.3 ± 479.6 
 
 
8628.3 ± 
27301.5 
 
 
0.28 0.28 
Mothers against decapentaplegic 
homolog 3  
2997.6 ± 1625.0 
 
 
3258.0 ± 3316.6 
 
 
0.76 0.08 
 
 
Table 4.3 (continued) 
 
 
Inflammatory Related Analytes  Time 1 Time 2 P SRM 
Interlukin 1 Beta  1129.1 ± 571. 
 
 
918.9 ± 491.7 
 
 
.20 -0.33 
Transforming growth factor beta-
1 
1509.0 ± 929.3 
 
 
1810.7 ± 1707.0 
 
 
0.46 0.19 
Tumor necrosis factor alpha  388.9 ± 208.3 
 
 
470.4 ± 422.4 
 
 
0.38 0.23 
Cartilage Related Analytes   Time 1 Time 2 P SRM 
Interstitial collagenase  
 
937.2 ± 586.9 
 
 
113.4 ± 977.2 
 
 
0.67 -0.11 
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Figure 4.1 Scatter plot depicting a significant (p=.009) positive linear relationship 
between time A matrix metallopeptidase 1 (MMP-1) and the change in insulin like 
growth factor binding protein 5 (IGFBP5).   
 
 
CHAPTER 5. PHYSIOLOGICAL CHANGES TO THE VASTUS LATERALIS AFTER NON-INVASIVE 
ANTERIOR CRUCIATE LIGAMENT INJURY  
Abstract  
Insufficient recovery of quadriceps muscle strength is commonly reported after 
anterior cruciate ligament (ACL) injury. Although weakness is secondary to a complex 
manifestation of neural inhibition, the extent and time course of morphological changes 
in muscle are largely unknown. Using a novel, clinically relevant animal model of ACL 
injury, a longitudinal study was performed to illuminate mechanisms underlying muscle 
atrophy. Purpose To investigate changes in cellular parameters underlying muscle 
function after non-invasive ACL rupture. Methods Male Long-Evans rats were randomly 
assigned to 8 groups (n=6-8 per group): one control group and seven groups after ACL 
injury (time after injury: 6, 12, 24, 48-hours, and 1, 2, 4-weeks). The right hindlimb of 
rats in the ACL-injury group were exposed to a single load of tibial compression to 
induce a non-invasive ACL rupture, followed by normal cage activity for designated 
time. The vastus lateralis (VL) muscles were immunoreacted for IgG, Pax7 and 
dystrophin to quantify muscle damage, satellite cell number and muscle fiber cross 
sectional area (CSA) respectively. The mRNA abundance of muscle RING-finger 
protein-1 (MuRF-1), muscle atrophy F-box (MAFbx) (markers of protein degradation), 
45s pre-rRNA (marker of ribosome biogenesis) and CD68 (marker for macrophage 
abundance) was determined by RT-PCR. One-way ANOVAs with Bonferroni post-hoc 
were used to determine differences between groups and paired t-tests were used to detect 
differences between limbs (P < 0.05). Results ACL injury resulted in a decrease in 
muscle wet weight (p=0.0003) and a trend toward reduced CSA (p=0.06) at 1-week post 
injury only, compared to control. CSA of the ACL injured limb was smaller than that of 
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the contralateral limb at 1-week only (p= 0.01). MAFbx mRNA abundance was 
significantly increased at 48-hours post-ACL injury (p=0.0001), with no differences for 
IgG, central nuclei, Pax7, 45s rRNA, total RNA concentration, CD68 or MuRF-1. 
Conclusions Results indicate that ACL injury induces atrophy which is transient and not 
related to muscle damage or changes in ribosome biogenesis but could be due to 
increased protein degradation. Based on these analyses future studies should focus on 
corroborating the increase in atrophic pathways and determining the presence of protein 
breakdown after ACL injury, to establish key therapeutic windows for targeting therapy-
resistant quadriceps weakness after ACL injury. Supported by K01AR071503. 
Keywords: Anterior cruciate ligament, quadriceps, atrophy  
 
Introduction  
Anterior cruciate ligament (ACL) injuries are one of the most common 
musculoskeletal injuries with an incidence rate of upwards of 200,000 cases a year.1 One 
detrimental result of ACL injury is persistent long term quadriceps atrophy and 
weakness.134-138 While the current standard treatment for ACL injury is surgical 
reconstruction, surgery does not entirely solve the problem of muscle atrophy.139 
Reconstruction surgery will reestablish joint congruity but patients who undergo surgery 
and those who remain ACL deficient will have quadriceps atrophy and weakness. 23,24,140 
ACL reconstruction and non-surgical treatment yield similar long term outcomes but 
when compared to the contralateral leg or healthy controls, patients who have town their 
ACL still have quadriceps atrophy and weakness.26 Furthermore, the incidence of 
developing post traumatic osteoarthritis (PTOA) is similar for patients who undergo 
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reconstruction as for those who remain ACL deficient (ACLD), indicating a need for 
interventions that will help preserve long term joint health. Patients with decreased 
quadriceps muscle strength have a higher incidence of PTOA likely due to the 
quadriceps’ inability to mitigate force through the joint. Therefore, elucidating the 
sources of quadriceps weakness following ACL injury is imperative in developing proper 
interventions.  
Quadriceps atrophy following ACL injury is multifactorial including alterations in 
neural inhibition17-19 and muscle morphology30,31,33. In comparison to what is known 
about alterations in neural inhibition, less is known about the cellular responses of the 
quadriceps muscle itself. Following ACL injury there are decreases in both physiological 
cross sectional area and fiber cross sectional area, with the largest decreases in the vastus 
lateralis between injured and non-injured limbs.29,30 There are also abundant increases in 
collagen content and fibrosis following injury31,33 that is associated with decline in 
satellite cell abundance.30,31 This could have important implications for function because 
increases in fibrosis and a decreased muscle stem cell abundance could limit muscle 
hypertrophy and muscle regrowth31. Additionally, there is a rise in myostatin expression 
in both the muscle and circulating serum levels33,35.Myostatin is an important muscle 
growth mediator34 and could be involved in atrophy following injury. Furthermore, 
studies looking at human muscle biopsies following ACL injury show higher levels of 
inflammatory mediators like TNFa and IL-633, presenting an inflammatory response in 
the muscle following joint injury. These studies provide an important first step in 
understanding the response of the quadriceps muscle following injury. Studies involving 
human subjects are mostly cross sectional and due to the variability and constraints of 
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human research, these studies are confounded by long periods between injury and biopsy 
as well as reconstruction surgery. Therefore, there is a need for longitudinal studies that 
will provide insight into timing and mechanisms underlying vastus lateralis atrophy after 
ACL injury.  
  Pre-clinical animal models of ACL transection provide a more controlled way to 
study the effects of ACL injury. The use of animal models allows researchers to study 
time points, like acutely after injury, that would not be feasible in human studies.  
However, transection surgery introduces more confounding variables similar to 
reconstruction surgery like an increase in inflammation and upregulation in certain 
atrophic markers.36,37,41  A non-invasive model of ACL injury would allow for a 
translational approach to determining the mechanisms responsible for muscle atrophy. 
Therefore, the purpose of this study was to use our in vivo pre-clinical model of ACL 
injury to systematically study the quadriceps muscle at several time points after injury. 
We hypothesized that following ACL injury, atrophy would set in early after injury, 
preceded by damage and inflammation in the muscle, and would continue for the duration 
of the study, up to four weeks after injury.     
Methods  
5.1.1 Animals  
 All procedures performed were approved by the University of Connecticut’s 
Institutional Animal Care and Use Committee.  Male Long Evans rats, aged 16 weeks, 
were used for this study. Animals were housed at the University of Connecticut division 
of animal research facility. Rats were kept in normal sized cages on a 12:12 light/dark 
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cycle and had access to food and water ad libitum. Rats were randomly divided into 
seven experimental groups (6 hr (n=6), 12 hr (n=6), 24 hr (n=6), 48 hr (n=6), 1 wk (n=8), 
2 wk (n=8), 4 wk(n=8)) and one sham uninjured group (n=6). The right hindlimb was 
subject to ACL tear and after recovery animals were euthanized corresponding to the 
group time point.  
5.1.2 ACL Tear 
Upon arriving at the vivarium, rats underwent a one week acclimatization period. 
Rats that were randomly assigned to the ACL injury group, underwent a reproducible 
non- invasive ACL injury using a single load of tibial compression. The custom device 
consists of two custom-built loading platforms. The top knee stage is rigidly mounted to a 
linear actuator (DC linear actuator L16-63-12-P, Phidgets, Alberta, CA) that positions the 
right hindlimb in 30 deg of dorsiflexion and 100 deg of knee flexion while providing 
room for anterior subluxation of the tibia relative to the femur. The bottom stage holds 
the flexed knee and is mounted directly above a load cell (HDM Inc., PW6D, Southfield, 
MI). Rats are anesthetized using an induction chamber with 5% isoflurane and 1L/min 
oxygen and maintained via a nose cone with 2% isoflurane and 500mL. The right 
hindlimb is subjected to single load of tibial compression at a speed of 8mm/s. ACL 
injury is noted by a release of compressive force during injury that was monitored via a 
custom program (LabVIEW, National Instruments, Austin, TX). Post-injury, study 
personnel perform a Lachman’s test to clinically confirm an ACL rupture has occurred 
and the hindlimb was palpated to check for the presence of gross bone deformity. If no 
contraindications were present, rats were returned to their cages and allowed to recover, 
no opioids or analgesics were administered due the ability for these drugs to alter normal 
61 
 
biologic responses. Following euthanasia rats were weighed and bilateral vastus lateralis 
muscles were harvested, weighed, flash frozen and stored at -80 degrees for further 
analysis. The right hindlimb was used for all analyses, except for CSA where both 
hindlimbs were utilized.  
5.1.3 Immunohistochemistry 
 IgG. To determine whether muscle fibers from the vastus lateralis exhibited overt 
muscle damage, fibers were immunoreacted for immunoglobulin G (IgG) 
infiltration141,142. Sections (8µm) were fixed in ice cold acetone (100%) for 10 minutes 
and washed in phosphate buffered saline (PBS). Slides were then incubated in fluorescein 
isothiocyanate-conjugated mouse anti-IgG (Invitrogen, Carlsbad, CA) overnight at 4°C. 
Following incubation, slides were washed twice in 5% bovine serum albumin and then 
once in PBS. To finish, sections were coverslipped using Vectashield mounting medium 
(H-1000, Vector Laboratories, Burlingame, CA). Images were captured using a Zeiss 
Axio Imager M1 microscope (Carl Zeiss, Göttingen, Germany). Five fields, taken to 
reflect the non-homogenous nature of the muscle, to ensure that all areas of the muscle 
were represented were photographed (100x) and subsequently analyzed using ZEN blue 
software (Carl Zeiss). Fluorescent intensity was quantified by the densitometric mean of 
each fiber (AU, arbitrary units) as previously described.142 IgG density, a marker of overt 
fiber damage was counted by a trained-blinded assessor. Pax7.  To quantify the 
abundance of Pax7+ cells (satellite cells)142,143, slides were fixed in 4% paraformaldehyde 
and underwent antigen retrieval at 92°C using sodium citrate buffer. Endogenous 
peroxidase activity was blocked using 3% hydrogen peroxide and then sections were 
incubated in Pax7 primary antibody (Developmental Studies Hybridoma Study Bank, 
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Iowa City, IA, USA) at a 1:100 dilution. Next muscle sections were immunoreacted with 
biotin conjugated secondary antibody (1:1000) (Jackson ImmunoReseach Laboratories, 
West Grove, PA, USA) and then streptavidin-horseradish peroxidase to amplify. Sections 
were then reacted with using TSA-Alexa fluor 488 (Invitrogen, Carlsbad, CA) and 
stained with DAPI to visualize nuclei. Pax7+/DAPI+ nuclei were expressed per number 
of muscle fibers. Dystrophin/Central Nuclei. Mean fiber cross sectional area (CSA) was 
determined by immunoreacting muscle sections with dystrophin (Thermo Fischer 
Scientific, Waltham, MA)  primary antibody for 1 hour at room temperature and then 
overnight at 4°C. Sections were incubated with directly conjugated goat-anti mouse 488 
secondary antibody. Sections were also immunoreacted with DAPI and then cover 
slipped with Vectashield mounting medium. Images were captured using Zeiss 
Axiovision software and Myovision analysis software144 was used to cculate mean fiber 
cross sectional area of each of the muscle fibers. Central nuclei were determined by 
counting all DAPI+ positive nuclei with clear separation from the dystrophin border by a 
blinded trained assessor145.  
5.1.4 RNA Isolation and Real Time RT-PCR 
RNA isolation was performed briefly as follows143,146. VL tissue was homogenized using 
a stick homogenizer in 1 mL of Trizol (Invitrogen, Carlsbad, CA). Homogenized muscle 
was spun at 12,000 g for 15 minutes and the supernatant was collected and added to 200 
µl chloroform. Tubes spun again at 12,000 for 15 minutes and the aqueous layer was 
taken for precipitation. Once precipitation occurred, the pellet was washed and 
reconstituted using RNAse free water. RNA concentration was measured using a Nano 
Drop (Thermo Fisher Scientific, Foster City, CA). Quantitative real-time reverse 
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transcription polymerase chain reaction (RT-PCR) was preformed using chemistry, 
protocol and the amplification and detection of Applied Biosystems (Thermo Fisher 
Scientific, Foster City, CA). For each sample cDNA was synthesized from 1 µg of total 
RNA using iScript Reverse Transcriptase according to manufacturer’s protocol (Biorad, 
Hercules, CA). Primers were selected using the Primer Design function of the Primer 
Express v1.5 software (Applied Biosystems, Foster City, CA) and were as follows: 18s 
(M11188) forward, TTCGGACGTCTGCCCTATCAA, reverse, 
ATGGTAGGCACGGCGACTA; tubulin (NM 022298) forward, 
GGCATGGAGGAGGGAGAGTT, reverse, CCAACCTCCTCATAATCCTTCTCTAG; 
β2-microglobulin (NM 012512.2) forward CGTGCTTG CCATTCAGAAAA, reverse 
GAAGTTGGGCTTCCCA TTCTC; muscle atrophy F-box (MAFbx) (NM 133521) 
forward, GACCTGCATGTGCTCAGTGAA, reverse, 
GGATCTGCCGCTCTGAGAAGT; muscle RING finger protein-1 (MURF1) forward, 
TGCCCTGCCAGCACAAC, reverse, GGATTGGCAGCCTGGAAGAT; 45s forward, 
GAACGGTGGTGTGTCGTT, reverse, GCGTCTCGTCTCGTCTCACT; CD 68, 
forward, TGTCTGATCTTGCTAGGACCG, reverse, 
GAGAGTAACGGCCTTTTTGTGA.  PCR reactions for 18s, b2-microglobulin, tubulin, 
MuRF1, MaFbx, 45s and CD68 were assemble using the SYBER Green PCT Master 
Mix, which only required the addition of cDNA template and the primers mentioned 
above. Data points for the standard curve were generated using threefold serial dilutions 
of pooled cDNA. The reactions were performed using ABI PrimsTM 7700 Sequence 
Detection System (Applied Biosystems) and the systems universal cycling conditions. 
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RNA abundance was expressed a ratio that was normalized to the Geomean (Tubulin, 18s 
and b2-microglobulin).143,146  
5.1.5 Statistical Analysis  
Using PRISM 8 software, one-way ANOVA with a Dunnett’s test was used to 
determine significance between ACL-injured groups and control. For within group 
comparisons, paired t-tests were utilized. All values reported are mean ± standard error of 
the mean (SEM) and statistical significance was assumed at P<0.05. 
Results  
There were significant differences in VL wet weight with the one-week time point 
being lower compared to control (p=0.001) and muscle weight to body weight ratios at 
the one-week (p=0.001) and two-week (p=0.025) time points being lower compared to 
the control group (Figure 5.1). Muscle fiber CSA was lower and trending towards 
significance at the one-week time point (p=0.06) compared to control. To confirm that 
this muscle atrophy seen at one week was due to the injury and not the animals losing 
weight we compared fiber CSA of the left (non-injured) and right (injured limbs).  The 
right limb at the one-week time point was significantly decreased compared to left 
(p=0.011) (Figure 5.2). 
 There were no differences in IgG infiltration between any of the experimental 
groups compared to control (p=0.310), indicating that the VL muscle did not undergo 
overt muscle damage in response to the ACL injury (Figure 5.3). There were also no 
differences in the number of central nuclei per fiber (p=0.690) (Figure 5.4). CD68, 
macrophage marker, mRNA abundance was not different between any of the 
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experimental groups and control (p=0.0363). mRNA abundance of TNFa, IL6 and IL10  
was not detectable in our tissues (Figure 5.5). There were no differences in Pax7+ 
satellite cells abundance between the groups (p=0.210) (Figure 5.6).  
Next we looked at specific atrophic markers, MuRF1 and Mafbx and found that  
Mafbx at the 48 hour time point (p=0.004) was significantly higher compared to control 
(Figure 5.7), but MurF1 was not different (p=0.296) at any time point. There were no 
significant differences in RNA concentration (p=0.221) or 45s pre-ribosomal RNA 
(p=0.368) (Figure 5.8).  
Discussion  
Results from this study show that following ACL injury atrophy of the quadriceps muscle 
begins as early as 1 week post injury. In our model we found fiber atrophy at one-week 
that was preceded by increases in an atrophic marker at 48 hours post injury. These data 
parallel previous longitudinal studies36,41 which showed increases in MaFbx and Murf1 
three days post ACL transection surgery. This is important because it provide insights 
into the period when atrophy is beginning which may have implications in developing 
interventions to treat muscle atrophy following ACL rupture. The model we utilized here 
is fundamentally different from other pre-clinical models considering the mode in which 
injury was induced.  Surgical ACL transection models confound the data because 
opening the joint during a transection procedure causes an increases in inflammation and 
upregulations in atrophic markers, in both the ACL transection group and the sham 
surgery group.36,41 Increases in protein degradation markers would imply that the atrophy 
seen in the quadriceps is a function of the surgery and not the injury.36 Our model is a 
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closed ACL injury, meaning we induce ACL injury without opening the knee joint. 
Therefore, the decreases we see in muscle size and increases in atrophic markers 
demonstrates that these processes are in fact caused by injury to the ligament and will 
happen regardless of surgery.  
 In conjunction with looking at markers of atrophy we also looked at RNA 
concentration, an indicator of ribosome quantity or translational capacity, and pre-
ribosomal RNA, an indicator of RNA transcription. Increases in pre-ribosomal RNA may 
indicate an increased capacity for ribosome biogenesis. While this is not a direct measure 
of protein synthesis, these markers could begin to discern changes in a cell’s capacity for 
protein synthesis.147 While our data did not find any differences in RNA concentration or 
45s pre-rRNA, we did see a rebound in muscle size. CSA was increased back to control 
level by two weeks, which could be due to the animals using their hindlimb more 
normally as they recover from injury but remains different from how humans respond to 
this injury, who do not recover muscle size. Animals in this study were allowed to use 
their limb unrestricted after ACL injury which is a departure from how human patients 
are treated; they are traditionally put in a brace following ligament injury. Bracing does 
not aid in restoring normal biomechanics or function to the joint148 and immobilization of 
the knee may aid in quadriceps atrophy.149 There is evidence to support that rehabilitation 
preceding ACL reconstruction is helpful in restoring patient function after surgery150,151 
but elucidating the timing of when atrophy begins, will help clinicians determine the most 
appropriate treatment immediately following injury. Furthermore, few studies have 
investigated changes in protein synthesis following ACL injury, but the interplay between 
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protein synthesis and degradation is important and futures studies need to determine how 
protein synthesis is changing in response to injury and an increase in atrophy.  
 This was one of the first study to investigate markers of muscle damage in the 
vastus lateralis following ACL injury. Along with IgG infiltration, to confirm the absence 
of overt injury, we counted central nuclei, and satellite cells which are necessary for 
muscle regeneration152, and also saw no differences in these markers in any of the 
experimental groups. The lack of damage insides fibers in our tissues demonstrates that 
our model was successful in administering a joint injury without disruption to the 
surrounding musculature and bone. This indicates that the atrophy we see at one week is 
due to the effects of ligament rupture and not a response to damaging stimulus. 
Moreover, we also found no differences in CD68 RNA indicating there were no 
differences in macrophage abundance between groups in the muscle. The lack of 
inflammatory markers in our muscle samples is a departure from what is seen in the 
human studies where inflammation has been detected in the vastus lateralis muscle33 and 
serum.35  Differences in the inflammatory response following ACL injury could be due to 
the length of time between injury and biopsy or the absence of surgical intervention in 
our model. Human studies looking at the effects of ACL injury on quadriceps muscle are 
limited by the timeframe in which they can collect samples from their patients and on 
average the time between injury and muscle collection is almost three months.30,31,33 It is 
likely that we did not find the same response in the muscle as previous human literature 
because our model was looking at acute post-injury time points and the response of the 
muscle may be different early after injury. In the time between injury and sample 
collection there is the possibility that patients could have been exercising or involved in 
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rehabilitation that may increase inflammatory markers in the muscle and serum.153,154 
This could explain the differences between the inflammatory response seen in the muscle 
of human subjects in previous studies and our model presented here.  
This study is not without limitations as this was the first step in beginning to 
understand how the quadriceps responds to closed ACL injury in the early acute phase 
after injury. Our latest time point was four weeks post injury and based on human 
literature it is likely that there may be alterations to the quadriceps as far out as three 
years after injury. We also did not include a sham treatment group in our studies to see 
how positioning the animal’s hindlimb into the apparatus only without the injury, would 
affect the muscle. Lastly, we did not look at any markers of fibrosis or protein breakdown 
and in the future,  these would be important additions. 
Conclusions  
This study was an important first step in understanding how ACL injury affects the 
quadriceps in the acute injury phase. This study utilized a novel device to induce a closed 
ACL tear and longitudinally studied the quadriceps muscle physiology over time.  There 
was no overt damage or inflammation to the muscle but there were upregulations in 
atrophic markers at 48 hours and fiber atrophy at 1 week that may be important in 
developing and implementing interventions to combat the muscle atrophy seen clinically. 
Future studies should focus on continuing to elucidate the mechanisms behind quadriceps 
atrophy in response to ACL injury. 
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Figure 5.1 Muscle weight is lower at 1 week post ACL injury indicating atrophy in the 
vastus lateralis. 
Differences in muscle wet weight between time points, “$” indicated that one week is 
different from control (p=0.001). Significant decreases in muscle weight to body weight 
ratio for the 1 week (p=0.001) and 2 week (p=0.025) time points compared to control 
(con (n=6), 6 hr (n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk 
(n=8)). All values reported are mean ± standard error of the mean (SEM). 
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Figure 5.2 Vastus Lateralis atrophy at 1 week following ACL injury.  
 
Representative pictures of vastus lateralis cross-sectional area stained with dystrophin 
(green) for control and 1 week groups. Decreases in fiber CSA at the 1 week time point 
trending towards significance (p=0.06). Significant decreases in fiber CSA in the right 
limb compared to the left limb for the one 1 week animals (p=0.011. Con (n=6), 6 hr 
(n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8). All 
values reported are mean ± standard error of the mean (SEM). 
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Figure 5.3 ACL injury does not cause overt muscle damage.  
 
Representative pictures of IgG photos from a control and 6-hour animal. No differences 
in IgG density between any of the time points (con (n=4), 6 hr (n=6), 12 hr (n=6), 2 hr 
(n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8)) and control (p=0.310). All 
values reported are mean ± standard error of the mean (SEM). 
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Figure 5.4 ACL injury does not increase the number of central nuclei.  
Representative images of central nuclei from a control and 48 hour animal. No 
differences in the number of central nuclei per fiber between any time point (con (n=4), 6 
hr (n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=7), 2 wk (n=8), 4 wk (n=8)) and 
control (p=0.690). All values reported are mean ± standard error of the mean (SEM).  
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Figure 5.5 No differences in CD68 mRNA abundance after ACL injury.  
There were no differences in CD 68 gene expression in the injured limb between any of 
the time point (con (n=6), 6 hr (n=4), 12 hr (n=6), 2 hr (n=6), 48 hr (n=5), 1 wk (n=7), 2 
wk (n=8), 4 wk (n=6)) compared to control (p=0.363). All values reported are mean ± 
standard error of the mean (SEM).  
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Figure 5.6 No differences in Pax7+ cells after ACL injury. 
Representative photos of Pax7+ cells (green) from control and 12-hour groups. There 
were no differences between Pax7+ cells per fiber between any of the time point (con 
(n=6), 6 hr (n=6), 12 hr (n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8)) compared to control 
(p=0.210). All values reported are mean ± standard error of the mean (SEM). 
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Figure 5.7 No differences in RNA concentration or pre-ribosomal RNA after ACL injury. 
RNA concentration is not different between control (con (n=7), 6 hr (n=6), 12 hr (n=6), 
24 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8)) and any other time point 
(p=0.221). There is no difference in 45s gene expression between control and every other 
time point (p=0.368). All values reported are mean ± standard error of the mean (SEM). 
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Figure 5.8 Difference in Murf-1 and Mafbx gene expression after ACL injury.  
Murf-1 gene expression is not different between control (con (n=7), 6 hr (n=6), 12 hr 
(n=6), 2 hr (n=6), 48 hr (n=6), 1 wk (n=8), 2 wk (n=8), 4 wk (n=8)) and any other time 
points (p=0.296). Mafbx gene expression is significantly higher at 48 hours when 
compared to control (p=0.004). All values reported are mean ± standard error of the mean 
(SEM). 
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CHAPTER 6. SUMMARY  
Purposes, Aims, and Hypotheses 
The purpose of this dissertation is twofold:  Firstly, to examine the relationship between 
serum, synovial joint inflammatory markers and proteomics in ACL deficient subjects; 
and 2. use those acquired data to identify cellular processes to track longitudinally in 
conjunction with changes in muscle size following a closed ACL injury in a rat model. 
These studies were designed to address the following aims and hypotheses: 
1. To determine if patients who remain ACLD have atrophy and weakness of the of 
the quadriceps compared to patients who undergo reconstruction.  
Hypothesis: Patients who remain ACLD will have similar 
functional outcomes as those who underwent surgery for isokinetic 
muscle strength, the single leg hop test and the IKDC. 
2. To assess inflammatory biomarkers before and after ACL reconstruction to 
determine if surgery results in a secondary inflammatory response. 
Hypothesis: We hypothesized that markers of inflammation 
(interleukin-1b, (IL-1b), interleukin-6 (IL-6)) are significantly 
increased following ACL reconstruction surgery. 
3. To determine whether muscle-related analytes are differentially expressed in the 
serum. 
Hypothesis: We hypothesized that proteins related to muscle would 
be increased in the serum after ACL injury, providing a means of 
transport to the synovial fluid.  
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4.  To use our in vivo pre-clinical model of ACL injury to systematically study the 
quadriceps muscle at acute time points after injury 
Hypothesis: following ACL injury there would be cellular changes, 
such as damage, inflammation and atrophy, to the vastus lateralis 
muscle. 
Summary of Findings  
The summary of findings for each specific aim are presented below. The findings include 
the following: 
1. To determine if patients who remain anterior cruciate ligament deficient (ACLD) 
have atrophy and weakness of the of the quadriceps compared to patients who 
undergo reconstruction.  
Findings: The findings of this CAT imply that non-operative treatments of 
ACL injuries are adequate options in restoration of patient function, as 
well as patient strength at long term follow ups. However, patients who 
remain ACL deficient still have atrophy and weakness of the quadriceps 
for years following injury.  
2. To assess inflammatory biomarkers before and after ACL reconstruction to 
determine if surgery results in a secondary inflammatory response.  
Findings: IL-1b concentrations significantly increased from the day of 
surgery to the first postoperative time point (p<.001) and significantly 
decreased at the 4-week postoperative visit (p=.03). IL-1b concentrations 
at the 4-week postoperative visit remained significantly greater than both 
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preoperative time points (p >.05). IL-6 concentrations at 1 week post-
surgery were significantly higher than at initial presentation (p=0.013), the 
day of surgery (p<0.001), and 4 weeks after surgery (p=0.002). ACL 
reconstruction appears to reinitiate an inflammatory response and appears 
to initiate a second “inflammatory hit”. 
3. To determine whether muscle-related analytes are differentially expressed in the 
serum. 
Findings: Proteins chitinase-3-like protein 1 (p= .01), insulin-like growth 
factor binding protein 1 (p= .01), insulin-like growth factor binding 
protein 5 (p= .02), renin (p=.004) and lymphotoxin alpha1: beta2 (p= .03) 
were significantly upregulated in serum following acute ACL injury. The 
current results confirm the inflammatory pattern previously seen in the 
synovial fluid thought to play a role in the progression of post traumatic 
osteoarthritis after ACL injury, and this data also provides further insights 
into important communication between the joint and quadriceps group, 
whose function is important in long term health.  
4. To use our in vivo pre-clinical model of ACL injury to systematically study the 
quadriceps muscle at acute time points after injury 
Findings: ACL injury resulted in a decrease in muscle wet weight 
(p=0.0003) and a trend toward reduced CSA (p=0.06) at 1-week post 
injury, compared to control. CSA of the ACL injured limb was smaller 
than that of the contralateral limb at 1-week only (p= 0.01). MAFbx 
abundance was significantly increased at 48-hours post-ACL injury 
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(p=0.0001), with no differences for IgG, central nuclei, Pax7, 45s rRNA, 
total RNA concentration, CD68 or MuRF-1.  
Synthesis of Results and Future Research Implications  
Several conclusions and implications for future research can be made based on the results 
of these studies.  
1. Patients who remain ACL deficient will have similar long term outcomes to those 
patients that undergo reconstruction surgery. Although compared to healthy 
controls and the contralateral side, patients who are ACL deficient will have 
atrophy and weakness of the quadriceps for years after injury.  
2. ACL reconstruction surgery reinitiates the inflammatory response within the knee 
joint. Furthermore, surgery creates an inflammatory burden that is two-fold higher 
than the initial ACL injury. The increased inflammatory burden has the potential 
to influence the systemic and muscular environments, chronic increases in 
inflammation may contribute to the detrimental side effects of ACL injury like 
quadriceps atrophy, weakness and the development of OA.  
3. Proteomic analysis revealed differences in upregulated proteins between ACL 
injury and ACL reconstruction related to inflammatory pathways. Additionally, 
upregulations in muscle related proteins provide a potential connection between 
the systemic and muscular environments.  
4. Pre-clinical models of ACL injury allow for a longitudinal, in depth study of 
muscle physiology following ACL rupture. We showed that following closed 
ACL injury there were no indications of inflammation or damage, there was 
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however, atrophy at one week post injury. Fiber CSA atrophy was preceded by 
increases in an atrophic marker, this may explain the decrease in muscle size and 
gives insight into when atrophic processes begin following injury.  
Conclusions  
This dissertation sought to connect the synovial, serum and muscular 
environments following ACL injury. We worked to determine how synovial joint 
inflammation would affect the systemic and muscular environments using both human 
and animal models. Our data began by elucidating that patients who do not undergo ACL 
reconstruction surgery and remain ACL deficient will still have atrophy and weakness 
long term when compared to healthy controls. This indicates that quadriceps atrophy 
following injury is a result of the ligament rupture and will happen regardless of 
reconstruction.  
Moreover, we found a large increase in synovial fluid inflammatory markers 
following surgery, almost two fold higher than the injury itself. These data highlight the 
impact of inflammation on the synovial environment and may have implications for the 
quadriceps muscle. In response to the large increase in synovial joint inflammation, we 
found increases in serum circulating inflammatory proteins indicating an increase in 
inflammatory pathways in the systemic environment. Additionally, there were 
upregulations in proteins that may be associated in regulating muscle size providing a 
connection between serum and the quadriceps muscle.  
To further characterize the response of the quadriceps we used a novel pre-clinical 
animal model of closed ACL tear. We looked at time points ranging from hourly after 
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ACL injury up to four weeks out following injury and found that without the presence of 
inflammation or damage in the muscle, the quadriceps muscle was still atrophied at one 
week following injury. This atrophy was preceded by increases in atrophy markers forty 
eight hours post injury and provides insight into when interventions may be appropriate. 
These data provide important first steps in characterizing the response of the synovial 
joint, serum and quadriceps muscle to ACL injury. Longitudinal studies like the one 
presented here provide valuable insight into when interventions should be applied and 
potential inflammatory targets. Future studies should focus on continuing to determine 
the specific communication factors between these environments and developing 
interventions to combat muscle atrophy following ACL injury.  
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